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SUMMARY 
Beta2-microglobulin (β2m) is a 99-residue globular protein that represents the light 
chain of the major histocompatibility complex class I (MHCI). β2m is responsible for two 
types of human amyloid diseases: dialysis-related amyloidosis (DRA) caused by wt β2m, and 
hereditary systemic amyloidosis due to the D76N β2m mutant. Two independent projects 
were carried out during my PhD studies addressing both types of β2m-related amyloidosis: 
(i) The human cells adopt a sophisticated unfolded protein response (UPR) system for 
targeting misfolded/aggregated polypeptides. However, the D76N variant, which is unstable 
and aggregation prone, bypasses the UPR system and reaches the extracellular space forming 
amyloids. To understand the mechanism(s) that allow the D76N variant to escape the UPR 
system and to characterize its effect on MHCI, we performed a complete structural and 
biophysical study on a MHCI bearing the D76N variant. Our results show that MHCI acts as a 
chaperone that stabilize and hide the amyloidogenic variant from the UPR system, and 
transfers it to cell membrane, where during its normal turnover, the D76N β2m variant 
dissociates into blood serum and aggregates causing human pathologies. 
(ii) The early oligomeric species are responsible for cellular cytotoxicity in 
amyloidosis. Previous data showed a favourable association interface (between two facing D 
β-strands) that may involve in β2m oligomerization. To further elucidate its role in 
aggregation, we created a S-S linked dimer of β2m (DimC33) that interacts via the DD 
interface. Our data show that DimC33 is highly amyloidogenic compared to wt β2m, 
suggesting that dimerization through DD interface is instrumental for enhancing its 
aggregation propensity. Furthermore, DimC33 was co-crystallized in complex with 
Thioflavin-T (ThT), a well-known amyloid-specific dye, showing unique ThT binding site 
that may indicate a second key interface involved in β2m oligomerization. 
PART I: STATE OF THE ART 
 2 
PART I 
1. STATE OF THE ART 
1.1 Amyloidosis 
 Amyloidosis is a serious pathological concern resulting from aggregation of precursor 
proteins or peptides into highly structured fibrillar aggregates called Amyloid fibrils. They are 
associated with various human amyloid diseases that can be broadly classified into three 
groups, according to the affected organ or tissue: Neurodegenerative diseases, such as 
Alzheimer’s and Parkinson’s disease; Non-neuropathic Localized Amyloidosis, such as Type 
II diabetes; and Non-neuropathic Systemic Amyloidosis such as Dialysis-related amyloidosis 
and light chain AL amyloidosis (1). Amyloidosis can result from unfolding of a natively 
folded protein, an amyloidogenic mutant variant of a protein, a cleavage of a protein into 
amyloidogenic fragments, a dramatic increase of a protein concentration, or over-production 
of an intrinsically disordered protein (2). 
 However, non-pathogenic and functional amyloids are also known to be part of 
various normal cellular life, performing useful functional roles. Notable examples include 
Curli fibrils expressed by E.coli that are involved in the colonization process (3), Spidroin in 
certain types of spiders for formation of silk fibers of the web (4), and  intralumenal fibrous 
striations in melanosomes upon formation of melanine molecules in mammalian system (5). 
 One of the most important characteristics of amyloid fibrils is the common cross-β 
arrangement of polypeptide chains along the fibril axis which is observable by X-ray powder 
diffraction pattern at 4.8Å and 10-11Å spacings (6) (see Fig. 1A&B), and by FTIR 
spectroscopy techniques. Amyloid fibrils have distinct fibrillar morphologies, which can be 
detected by Transmission electron microscopy (TEM) and Atomic-force microscopy (AFM).  
 The most common methods for detection and diagnosis of amyloid fibrils are achieved 
by amyloid binding dyes, such as Congo Red staining and Thioflavin-T (ThT) fluorescence. 
ThT is considered the gold standard for effective and reliable in vitro and in vivo analysis of 
amyloid fibrils (7, 8); upon binding to amyloid fibrils, ThT exhibits a dramatic shift in its 
fluorescence excitation and emission maxima, from 385 nm to 450 nm, and from 445 nm to 
482 nm, respectively.  
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1.2 Dialysis-related amyloidosis  
 In 1980, Assenat et al. discovered, for the first time, amyloid fibril deposits in a tissue 
removed from patients undergoing long-term dialysis during carpal tunnel syndrome surgery 
(9), in which, β2m was the major component of such amyloid deposits (10-12). 
 The onset of dialysis-related amyloidosis (DRA) originates from gradual increase of 
freely circulating serum concentrations of monomeric β2m, up to 60-fold (13), in patients 
undergoing hemodialysis due to kidney failure—where dialysis membranes were insufficient 
to degrade and eliminate β2m outside of human body. A simple schematic view 
characterizing the onset of dialysis-related amyloidosis is shown in Fig. 1C. The impairment 
of β2m system clearance results in an accumulation of the latter as amyloid fibrils in 
osteoarticular tissues, in cartilage, capsule and synovium, showing clinical symptoms of 
carpal tunnel syndrome accompanied by amyloid arthropathies in the spine and peripheral 
joints leading to bone fractures (14).  
 
Figure 1. (A) Common cross-β structure of amyloid fibrils (figure acquired from Biancalana M, et al. Biochem. 
Boiphys. Acta, 2010) (15). (B) The characteristic cross-β  X-ray powder diffraction pattern of amyloid fibrils 
(figure is modified from Stroud et al. PNAS, 2012) (16). (C) Schematic representation of main steps in the 
pathogenesis of dialysis-related amyloidosis (figure acquired from Hodkinson JP, et al. Book chapter:Common 
Cytotoxins Underlying Degenerative Diseases 2012) (17). 
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 The mechanism of DRA is complex and yet to be elucidated at molecular level; 
several in vitro analyses showed that β2m is very stable and soluble under long term 
incubations under physiological conditions (37°C, pH 7,4), even at 20-folds higher than in 
vivo concentrations that occur during DRA, suggesting that β2m serum concentration increase 
on its own is insufficient to self-initiate amyloidosis (18). Other factors have been shown to 
trigger full length β2m amyloidosis, such as: post translational modifications of β2m (19), 
binding to divalent metal ions (20), glycosaminoglycans (21), heparins (22), collagen (23) etc. 
1.3 Structure and Function of β2m  
 In higher organisms, β2m is a component of major histocompatibility complex class I 
(MHCI) molecules (24), as well as MHC-related molecules called haemochromatosis protein 
(HFE) that have a role in regulating iron homeostasis (25). MHC class I molecules are 
expressed abundantly on the surface of nearly all nucleated cells that play a key role in cell-
mediated immune system by presenting antigens to CD8-positive T cells. Mature MHC class 
I molecules consist of one membrane-linked heavy chain, a non-covalently linked β2m, and a 
8-10 amino-acids long antigen that is generated from cytosolic proteins by cellular 
proteasomes (26) (see Fig. 2A).  Assembly of MHC class I molecules occur in the 
endoplasmic reticulum (ER), followed by transit through the Golgi apparatus to the cell 
surface. During their normal turnover, the class I MHC molecules dissociate, releasing β2m 
and antigen extracellularly, whereas the membrane-associated heavy chain internalize for 
recycling or degradation (24). In healthy individuals, the catabolic degradation of β2m occurs 
in the proximal tubular cells, in the kidneys (27, 28). 
 β2m is a 99-residue small globular protein with a typical immunoglobulin-like fold 
composed of seven β-strands (named alphabetically from A-G) arranged in two β-sheets; four 
β-strands (ABDE) form one β-sheet and the remaining three β-strands (CFG) form the facing 
β-sheet; the two β-sheets are internally cross-linked by one disulfide bond via Cys25 and 
Cys80 (29) (pdb code: 2YXF) (Fig .2B). The disulfide bond is well protected from reduction 
in the native state as well as in amyloid fibrils of β2m (30, 31), and is shown to be necessary 
for proper formation of mature amyloid fibrils (32). The NMR (33) and X-ray crystal 
structures (34) of natively folded β2m showed a cis conformation for the His31-Pro32 
peptidyl-prolyl bond. 
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Figure 2.  X-ray crystal structures of MHC class I and β2m.  
(A) 3D model representation of MHC class I (pdb code: 1JF1) showing the heavy chain with three α domains 
(α1, α2, α3) in green, the light chain (β2m) in magenta and the peptide bound in a groove between two helices 
of heavy chain is shown as sticks model in red. (B) 3D model of monomeric β2m is shown in Cyan: the most 
important residues are shown as sticks model and N-terminal six residues are shown in red (pdb code:2YXF). 
(C) The superposed models of MHC bound conformation of β2m (pdb code: 1JF1) with free-form of wt β2m 
(pdb code:2YXF), where the two variable conformations of AB-loop is seen on the upper side of the molecule. 
 The main β2m regions that interact with the heavy chain of MHCI include β-strands A 
and D, AB-loop, BC-loop and DE-loop (35) (pdb code: 1JF1), (Fig. 2A). Those regions 
exhibit dynamic flexibility in the free-form of β2m compared to bound conformation with the 
heavy chain of MHCI, (see Fig 2C) (36, 37), and were hypothesized to be directly involved in 
amyloid fibril formation, (38-40). The Trp60 in DE-loop region plays a key role in complex 
formation with the heavy chain of MHCI as well as in amyloid fibrils (41) (Fig. 2A, B). 
Indeed, the Trp60 substitution to Gly, diminished its assembly within MHCI molecules, 
abolished its amyloidogenic propensity, and increased its solubility and stability compared to 
wt β2m (42). Whereas, Asp59 substitution to Pro decreased its stability and increased its fibril 
formation capacity, suggesting that conformational strain in the DE-loop may be crucial for 
β2m stability and aggregation (38, 39).  
1.4 β2m folding and amyloidosis 
Chiti and co-workers characterized the folding process of β2m by a three sequential 
phases model with two intermediates: the burst phase, with the formation of partially folded 
conformers showing partially exposed hydrophobic core (I1); the fast phase, with the 
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conversion into more compact and highly structured species (I2); and the slow phase, with the 
formation of the final native state (N) see Fig 3.  
 
Figure 3. Schematic representation of β2m four state model (figure obtained from Chiti et al. J Mol Biol. 
2001) (43). 
 It’s worth mentioning, that partially folded intermediate species (I2) closely resemble 
the amyloidogenic species of β2m that are generated under mildly acidic pH conditions (43). 
Under some physiologically relevant conditions, a 14 ± 8% amount of (I2) species was shown 
to populate at equilibrium with (N) species, displaying a 5-fold higher aggregation rate 
compared to the native (N) ones, in the presence of ex vivo amyloid seeds (44). 
 Chiti and his colleagues proposed that the slow phase of β2m folding refers to the 
presence of substantial energetic barriers, and is unrelated with trans to cis isomerisation of 
His31-Pro32 peptidyl-prolyl bond, since it lacks any sensitivity to peptidyl prolyl isomerase 
during the slow phase of β2m folding (43). Later on, NMR and CD studies on β2m mutants, 
allowed to conclude that trans to cis isomerisation of His31-Pro32 peptidyl-prolyl bond was 
in fact responsible for the slow phase of β2m folding, and for the accumulation of I2 species. 
The Pro32 substitution to Val/Gly completely abolished the slow folding phase of β2m by 
allowing it to maintain a trans isomeric conformation at the His31-Val32 peptide bond (45, 
46). However, the Pro32 to Val β2m variant was unable to elongate the ex vivo amyloid 
fibrils, suggesting that the trans peptide form at position Pro32 is insufficient on its own to 
trigger self-oligomerisation and fibril formation (46).  
 In order to better study the conformational effects of Pro32 in β2m folding and 
aggregation, Torbeev et al. deployed fluorinated derivatives of Proline amino acid in order to 
modify the equilibrium rates in the cis to trans isomerization at the His31-Pro32 peptide 
bond; the results showed a direct influence of Pro32 isomerization rates on stability, folding a 
aggregation properties of β2m (47).  
 In a pioneering work, Rennella et al. characterized the oligomeric species that populate 
during acid denatured β2m folding by means of hybrid techniques, including real-time 2D 
NMR, small-angle X-ray scattering (SAXS) and ThT fluorescence (48). They identified the 
presence of oligomeric species (mainly dimers) along the folding process of β2m, with the 
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long-lived intermediate (I) species having 6 to 7-fold higher rates of self-assembly into dimers 
compared to the native ones (N). The dimeric species had elongated shapes as a result of head 
to head interaction at the apical side of β2m where Pro32 is located (see Fig. 4B, C), 
suggesting that cis-trans isomerization of Pro32 could play a key role in oligomerization and 
fibril formation (48). In accordance with their findings, they proposed a five-state model of 
β2m folding that better describes the formation of dimeric species (see Fig. 4A).  
Figure 4. kinetic folding model of β2m oligomers.  
(A) Five-state kinetic folding model of β2m, where the three dimeric species that accumulate along the folding 
process of β2m are included: I2-intermediate homodimer, N2-native homodimer, IN-intermediate-native 
heterodimer. (B, C) Surface representations of monomeric and head to head dimeric models of β2m observed by 
SAXS analysis. (figures were modified from Renella et al. J Mol Biol. 2013)(48).  
 A similar head to head dimerization interface of two β2m was also reported by NMR 
studies of Pro32 to Gly β2m variant (45), in three crystal structures of DimC20, DimC50 
engineered β2m (49), the hexameric structure of H13F β2m variant (50), as well as by 
molecular dynamics simulation studies of β2m aggregation (51). 
 Clinical studies performed on patients being treated with long-term dialysis due to 
kidney failure, revealed a clear link between Cu+2 coated dialysis membranes and DRA (52, 
53). It has been shown, that Cu+2 binds to the natively folded β2m through His31 
(dissociation constant ~2.7 µM) with a binding specificity for Cu2+ over Zn2+ and Ni2+ (54). In 
the early stages of Cu+2-induced β2m fibrillogenesis, Cu+2 is shown to convert the native-state 
β2m into an active native-like conformation by inducing cis to trans isomerisation of  His31-
Pro32 peptide bond that triggers the formation of dimeric species, and later on assembles into 
higher order species of tetramers and hexamers, eventually forming amyloid fibrils (55). Cu+2 
can also bind to the unfolded-states of β2m mediated by His13, His51, His84 residues 
excluding His31 (20), causing destabilization of human β2m and leading to oligomerization 
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to dimers and tetramers along the amyloid fibril formation (56, 57).  
1.5 The role of ∆N6-β2m in dialysis-related amyloidosis 
 The analysis of ex vivo β2m amyloid fibrils extracted from a patient suffering DRA 
revealed the presence of over 20% of N-terminally truncated species of β2m (Fig. 2B), mainly 
at positions Arg6 (called ∆N6-β2m), and less commonly at Tyr10 (30). The ∆N6-β2m variant 
is shown to have affinity for collagen (58), which may indicate its essential role in DRA by 
triggering amyloidosis at collagen rich regions in the human body. 
 The ∆N6-β2m truncated species were less stable and highly susceptible for proteolytic 
degradation in comparison with wt β2m; they readily formed amyloid fibrils at physiological 
pH (7.4) and temperature (37°C) conditions, without addition of any pre-formed amyloid 
fibrillar seeds or additives (19, 59). The real-time NMR studies of the ∆N6-β2m variant 
showed a trans-isomer at position Pro32, accompanied by global conformational 
perturbations of β-strands A, C and partially B, although the tertiary structure was intact due 
to the preserved disulfide bond at Cys25 and Cys80 (19); the non-native conformation of 
∆N6-β2m resembled, to a great extent, the slow-phase intermediate (I2) species of β2m (40). 
Molecular dynamics simulations of the ∆N6-β2m variant suggested that the D-strand is 
directly involved in early oligomerization interfaces leading to amyloid fibril formation (19).  
 The ∆N6-β2m variant possesses a prion-like catalytic activity promoting the 
transformation of human wt β2m into non-native amyloidogenic intermediates able to form 
amyloid fibrils (40). In a recent study, Karamanos and co-workers showed that the interaction 
between amyloidogenic ∆N6-β2m and human β2m (Hβ2m) results in promotion of 
amyloidosis, whereas the interaction between ∆N6-β2m and mouse β2m (Mβ2m) results in 
inhibition of amyloidosis; in both cases, the same head to head interaction site at apical region 
of β2m (BC and DE loops) was shown to be involved in inhibition or activation processes of 
amyloidosis (60). 
1.6 β2m amyloid Fibrils 
 β2m-related amyloidosis results from an accumulation of specific amyloidogenic 
precursors alongside the destabilization of natively folded β2m; the relative population of 
different amyloidogenic precursors is responsible for in vitro amyloid polymorphism (61). 
Indeed, in an acidic pH environment, the stability of β2m decreases causing it to adopt a 
partially unfolded conformation favoring aggregation (62). The pH and ionic strength of the 
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solution can dramatically influence the fibrillogenesis of native β2m; for instance, under 
acidic conditions (pH 3.6 – 4.0) and high ionic strength (400mM NaCl), β2m spontaneously 
forms amyloid fibrils, without any observable nucleation phase, displaying short (50-200 nm) 
and curvilinear worm-like fibril morphology (62). However, at slightly higher pH (> 3.0) and 
low ionic strength conditions (>30mM NaCl), β2m assemble in a nucleation-dependent 
manner, forming longer amyloid fibrils that are much similar to ex vivo fibrils (62, 63). The 
studies on early stage assembly mechanisms revealed that worm-like fibrils were assembled 
by constant addition of monomeric species, whereas the long-straight fibrils were formed by a 
population of oligomeric species (monomers, dimers, trimers and tetramers), which was then 
accumulated in the nucleation phase forming amyloid fibrils (64).  
 Since natively folded wt β2m species are unable to form amyloid fibrils for long time 
periods at neutral pH (7.4) in vitro, the addition of preformed amyloid seeds and denaturants 
such as 2,2,2,-trifluoroethanol (TFE) or Urea (21) were proposed, in order to trigger and 
accelerate wt β2m amyloidosis, allowing its characterization and analysis under in vitro 
conditions. By using a combination of biophysical techniques, Santambrogio et al. studied the 
conformational intermediates that generate under neutral pH in the presence of 20% TFE, and 
under low-acidic pH conditions: in both cases, partially folded species were populated at 
room temperature, showing a predominant beta type intermediate under low-pH condition 
compared to helical type under TFE-induced condition (65).  
 The addition of physiologically relevant factors to the fibrillogenesis solution, such as 
heparin, serum amyloid P component (SAP), apolipoprotein E (apoE), uremic serum, or 
synovial fluid, was shown to dramatically increase the rates of amyloid fibril formation due to 
its stabilizing effect on pre-fibrillar seeds (18). A crucial role for collagen in β2m-related 
amyloidosis under physiological conditions was also presented, due to collagen’s 
immobilized charged surface that can act as seed to concentrate β2m molecules and prompt 
them to interact with each other more efficiently (66). 
1.7 β2m oligomeric species in amyloidosis 
Understanding the chain of events responsible for amyloid fibril formation is essential 
for identification of new targets for drug design against amyloidosis. A growing evidence 
suggest the role of oligomeric species in cellular cytotoxicity (67). During the early phase of 
β2m amyloidosis, intermediate oligomeric species are generated that eventually self-
aggregate into mature amyloid fibrils (68). However, the molecular mechanism(s) responsible 
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to convert the monomeric species of native β2m into amyloidogenic precursors favoring 
oligomerisation is yet to be elucidated. Moreover, the oligomeric species are non-
homogeneous and transient species, which makes their characterization at molecular level a 
challenging task. The cryo-electron microscopy analysis of full-length wt β2m amyloid fibrils 
revealed a globular dimer of dimers arrangement of fibrillar structure, with at least three 
different subunit interfaces involved (69). The IMS-MS characterization of β2m oligomers 
formed at acidic pH (3.6) conditions revealed the presence of a dynamic fast interchanging 
pool of oligomeric species, ranging from dimers to hexamers, together with the monomers 
(70).  
 In order to further characterize the oligomeric species of β2m at a molecular level, 
Miranker and co-workers engineered two separate β2m mutants, P32A β2m and H13F β2m, 
which were able to form oligomeric species when incubated in the presence of Cu+2. The 
P32A β2m variant was crystallized as a dimeric species, showing a dimerization interface 
mediated by continuous anti-parallel D-strands (Fig. 5C). The characteristic β-bulge located 
at Asp53 of the edge-strand D (which was previously suggested to serve as natural inhibitor 
of aggregation) was absent, due to the conformational rearrangements required to 
accommodate a trans conformation of peptide bond at P32A mutation site (71).  
 The H13F β2m variant was crystallized as hexamers that also had a trans-
conformation of the His31-Pro32 peptide bond. Two distinct interfaces were identified in the 
hexameric structure of H13F β2m: the first interface was formed by a head-to-head 
arrangement of two β2m molecules showing an anti-parallel DD strands interface (see Fig 
6A); the second interface was mediated by two adjacent ABDE sheets interacting with each 
other through stacking of the aromatic residues Tyr 10, Tyr26 and Tyr63 (see Fig 6D) (50). 
Later on, the same authors showed that the same ABDE sheets interface in the hexameric 
structure of H13F β2m can bind Thioflavin-T via stacking interactions with Tyr10 and Tyr26 
residues (72) (see Fig 6E). However, the oligomeric species generated by P32A and H13F 
β2m variants failed to form any amyloid fibrils in solution, raising concerns on their relations 
with on pathway intermediate species preceding β2m aggregation (73).  
 Selective covalent labeling combined with mass spectrometry technique was 
performed to study the residues involved in interfaces of the oligomeric species that 
accumulate during the early stages of Cu+2-induced β2m fibrillogenesis (74).  The results 
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proposed an anti-parallel ABDE sheets interaction of two monomeric β2m for formation of 
the dimeric interfaces (75), and D strands interaction of one dimer with G strands of the 
adjacent dimer, for formation of the tetrameric interfaces (76). 
 In a different study, nanobodies were implemented to block and characterize the 
amyloidogenic intermediate of ∆N6-β2m at atomic resolution (77). The crystal structure of 
nanobody-trapped ∆N6-β2m revealed a domain-swapped dimer as a result of G strands 
exchange between two ∆N6-β2m molecules; the remaining core structure maintained its 
native-like conformation due to the intact disulfide bond between Cys25-C80 (see Fig 5A). 
As a result of domain swapping, the FG-loops of two ∆N6-β2m chains corresponding to 
residues 83-89  (NHVTLSQ), formed two new anti-parallel β-strands (see Fig 5A); the 
isolated heptapeptide (NHVTLSQ) was shown have intrinsic properties to self-aggregate and 
form amyloidogenic β-sheet interactions (78).  
A further attempt to characterize intermediate species of β2m came from Eisenberg 
and colleagues; they isolated and solved the crystal structure of a covalently linked domain-
swapped dimer from on-pathway oligomeric species of β2m amyloidosis in the presence of 
reducing agents (79). The swapped domains of E, F and G strands were covalently linked to 
the host domain by a disulfide bond created by Cys25 and Cys80 of different molecules (see 
Fig. 5B). The hinge loop connecting the two domains (LSFSKD) was shown to have internal 
amyoidogenic segments, and the crystal structure of the isolated hexapeptide (LSFSKD) 
revealed a class 5 steric zipper similar to other amyloid backbone structures (79) (see Fig. 
5D). 
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Figure 5. 3D cartoon representations of β2m oligomeric variants: (A) two chains of the ∆N6-β2m domain-
swapped dimer are shown in Yellow and Cyan, (pdb code: 2X89); (B) two chains of the full length β2m domain-
swapped dimer are shown in Green and Cyan (pdb code: 3LOW); (C) two chains of the P32A variant β2m that 
interact via two continuous anti-parallel D-strands are shown in Magenta and Green (pdb code: 2F8O); (D) Four 
chains of the hexapeptide (LSFSKD) forming class 5 steric zipper are shown in Cyan (pdb code: 3LOZ). 
Recently, three covalently bonded homodimers of β2m were engineered in an attempt 
to study the protein-protein interaction sites involved in early oligomerisation steps of 
amyloidosis (49). As a result, three independent Cys mutations were introduced at surface 
sites of β2m, at residues 20, 50 and 88, and used to prepare disulphide-bonded homodimers of 
β2m, and named DimC20 (i.e. two β2m molecules linked through a Cys20-Cys20 disulphide 
bond), DimC50 and DimC88, respectively. Interestingly, DimC50 and DimC20 were 
crystallized as tetramers; a head-to-head arrangement of dimers were observed, mediated by 
an anti-parallel DD strands interface (see Fig. 6B, C), similar to the previously discussed DD 
strands interface in the hexameric structure of H13F β2m variant (Fig. 6A) (50). The DimC50 
and DimC20 were amyloidogenic in solution, triggering the formation of long straight fibrils, 
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whereas, DimC60 was not amyloidogenic, apparently due to the disulfide bond position in 
DimC60 that interferes with the formation of the DD strands interface. Therefore, it was 
suggested that the DD interface may be directly involved in the formation of β2m oligomeric 
species under native and non-native conditions (49).  
 
Figure 6. 3D cartoon representations for β2m oligomeric variants: (A) two chains of hexameric H13F β2m 
variant forming a dimeric DD strands interface are shown in Magenta and Pale-green, (pdb code: 3CIQ); (B) two 
chains of DimC20 interacting through a DD strands interface are shown in Blue and Yellow (pdb code: 3TLR); 
(C) two chains of DimC50 forming a dimeric DD strands interface are shown in Magenta and Green (pdb code: 
3TM6). (D) two chains of hexameric H13F β2m variant interacting through ABED sheets are shown in Magenta 
and Pale-green, (pdb code: 3CIQ); (E) two molecules of Thioflavin (ThT) in 50% occupancy, is shown as sticks 
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model in Cyan, bound between two ABDE sheets interface formed in hexameric structure of H13F β2m are 
shown in Magenta and Pale-green (pdb code: 3MZT). 
1.8 Inhibition of amyloidosis 
 Several strategies have been proposed to inhibit the formation of amyloid fibrils, 
including the stabilization of protein’s native state or blocking the fibril formation by small 
molecules (80), monoclonal antibodies (78), small hydrophobic gold nanoparticles (81), 
chaperons (82), or by engineering new proteins to bind the amyloidogenic peptide/protein and 
prevent its aggregation (83).  
 Small molecules such as rifamycin SV (80), tetracycline and its analogues (84) are 
known to exhibit potent inhibiting effect on β2m amyloid fibril formation. It has been shown 
recently, that doxycycline inhibits β2m amyloidosis by stabilizing the native-state of β2m and 
blocking its oligomerisation process (84) with an overall IC50 value of ~ 47 µM (i.e. reducing 
the ThT  fluorescence binding signal by 50%). The NMR studies revealed that the stabilizing 
effect of doxycycline results from transient interactions made with β2m specific regions 
including the end of the A strand, the initial part of strand B and the AB loop (85). Molecular 
dynamics simulation studies also indicated a very similar interaction site of doxycycline with 
β2m, through stacking interactions of doxycycline with Tyr10 located at the A strand region 
of β2m (86). Clinical analysis conducted on three patients suffering DRA showed positive 
effects of 100mg doxcycycline daily treatment: articular pain was decreased, passive and 
active movements were improved, but the amount of amyloid deposits remained unchanged 
(87).  
 Many amyloid inhibitors are rich in aromatic residues, sharing common structural 
features with ThT (88), a universal amyloid binding dye; therefore, a thorough investigation 
on the β2m ThT binding site at atomic resolution would be instrumental for driving effective 
drug-design against β2m amyloidosis (15).  
1.9 Hereditary systemic amyloidosis due to D76N β2m variant.  
 In 2012, Valleix and colleagues reported a newly discovered autosomal dominant 
hereditary systemic amyloidosis caused by a single mutation of Aspartic acid at position 76 to 
Asparagine in β2m (89). The affected members of a French family suffered from a 
progressive bowel dysfunction, with extensive visceral amyloid deposits; symptoms included 
chronic diarrhoea, weight loss, sicca syndrome, subsequent symmetric sensorimotor axonal 
polyneuropathy, and severe orthostatic hypotension (90). Unlike DRA, the renal function and 
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plasma concentrations of freely circulating β2m in this case were normal. The amyloid 
deposits were located in the spleen, liver, heart, salivary glands, and nerves of the patients. 
Despite the fact that the four affected patients were heterozygous for the D76N β2m mutant 
encoding gene, amyloid fibrils were solely composed of the full length D76N β2m variant 
(meaning that wt β2m were also expressed but not integrated into any amyloid).  
 In contrast to wt β2m, the D76N β2m variant was less stable to unfolding by 
approximately 2 kcal/mol, as measured through guanidine hydrochloride denaturation. 
Moreover, the D76N variant showed high tendency to form amyloid fibrils in vitro under 
physiologic extracellular conditions within a few hours of incubation with agitation at 37°C, 
and without addition of Heparin or pre-formed amyloid seeds; notably, under such conditions 
wt β2m is completely soluble (91). The crystal structure of the D76N β2m variant matched 
closely those of the wt β2m structure; the main differences included the 1.5 Å shift of Tyr78 
towards Asn76, the formation of new hydrogen bonds with the amide N atoms of Thr73 and 
Asn76 (Fig. 7A, B), as well as the change in the theoretical isoelectric point from 6.05 to 6.40 
and the formation of more positively charged molecular surface (Fig. 7C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Crystal Structure of D76N β2m variant. 
Panel A is a ribbon representation of the D76N variant. Panel B is a close-up view of the EF-loop (residues 70 
to 80) shown in Panel A, superimposed on the wt β2m structure (blue–green). Residues belonging to the D76N 
variant are in yellow, and Tyr78 belonging to wt β2m is blue–green; hydrogen (H) bonds are shown as dashed 
lines. Panel C shows the surface electrostatic potential of the EF-loop region in the D76N variant (top) and in wt 
β2m (bottom); circles indicate the mutated residue. Blue represents positively charged regions, and red 
negatively charged regions (Figure obtained from Valleix et al. NEJM, 2012) (89). 
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2. AIMS OF THE THESIS 
Despite the fact that a great variety of precursor proteins and peptides are responsible 
for different types of amyloid-related diseases, they all end up producing amyloid fibrils with 
shared structural and biophysical characteristics. β2m is a protein responsible for Dialysis-
related amyloidosis and for a recently discovered hereditary systemic amyloidosis due to 
D76N β2m variant, which makes it an important model to study the underlying mechanisms 
in full-length protein amyloidosis. Two parallel research projects were carried out during my 
PhD studies, addressing both types of β2m-related amyloidosis independently, in order to 
explore the potential effect(s) of the D76N β2m variant on MHCI molecules, and to 
discover/characterize the oligomeric interfaces involved in β2m oligomerization and amyloid 
fibril formation in DRA. 
2.1 MHCI: the Trojan horse for secretion of amyloidogenic β2m 
The newly discovered D76N β2m mutant is so far the only known pathologic mutant 
of human β2m, and it is responsible for a hereditary systemic amyloidosis. Although the 
D76N β2m variant is very unstable and aggregation prone, it is not cleared by the cellular 
unfolded-protein response (UPR) system, and is found abundantly in extracellular amyloid 
deposits. Physiologically, β2m is the light chain of the class I major histocompatibility 
complex (MHCI) that plays a pivotal role in cellular immune response. Therefore, focusing 
on the biophysical and structural properties of MHCI bearing the D76N β2m variant as light 
chain (MHC76) will help us to understand how such aggregation prone variant is protected 
from degradation, shedding light on the pathogenesis of this newly discovered misfolding 
disease. 
2.2 A covalent homodimer to probe early oligomers along amyloid aggregation 
During the early stages of amyloid fibril formation, heterogeneous and transient 
oligomeric species are accumulated, which represent the building-blocks for initiation and 
elongation of amyloid fibrils. Moreover, the primary role of oligomeric species in cellular 
toxicity was highlighted by many literature reports. The self-assembly mechanisms of β2m 
oligomeric species are still unclear, and, in particular, the atomic resolution description of 
regions involved in β2m oligomerization is yet to be elucidated. Dimeric intermediate species 
are shown to populate during the folding process of β2m that are highly amyloidogenic and 
aggregation-prone; those species display elongated shapes as a result of head to head 
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interaction of two β2m molecules through an anti-parallel DD strand interface. In several 
independent crystal structures of β2m variants, we also observed a similar anti-parallel DD 
strand interface formed between two interacting β2m molecules, suggesting that such 
interface may be directly involved in β2m dimerization and amyloidosis. In this study, we 
investigated the role of such DD strand interface in β2m oligomerization and amyloid fibril 
formation at molecular level, by constraining two β2m molecules to interact via such DD 
strand interface by mutating Ser33 to Cys, and preparing the corresponding S-S covalent β2m 
homodimers (DimC33). 
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3. MAIN RESULTS 
3.1 MHCI: the Trojan horse for secretion of amyloidogenic β2m 
3.1.1 MHCI reconstitution 
The potential effect of D76N β2m variant on the MHCI assembly was studied in 
comparison with the wild-type counterpart, by generating four different species of MHCI 
molecules bearing the D76N variant or wt β2m in the presence of short peptides—a 8 to 10 
amino-acids long peptide is necessary for a proper MHCI folding, whose stability also 
depends on the bound peptide. In order to rule out specific effects mediated by the bound 
peptide, two different peptides were used for production of MHCI, NY-ESO1(Y1V9) and 
FR20(Y3). The selected epitopes NY-ESO1(Y1V9) and FR20(Y3) are modified peptide 
variants from the melanoma-associated antigen NY-ESO1 (92), and multiple myeloma-
associated antigen FR-20 (93), respectively. Both epitopes have been modified in order to 
enhance the overall stability of HLA-A0201 complexes. While peptide positions 1 and 9 were 
mutated to Tyr and Val (pY1 and pV9, respectively) in NY-ESO1(Y1V9), residue 3 was 
changed to Tyr(pY3) in FR20. 
The prototypic HLA-A0201 (HLA-A2) heavy chain was refolded in the presence of 
D76N β2m or wt β2m, and of NY-ESO1(Y1V9), or FR20(Y3). As a result, four MHCI 
species were generated the HLA-A2/wt-β2m/NY-ESO1(Y1V9), HLA-A2/D76N-β2m/NY-
ESO1(Y1V9), HLA-A2/wt-β2m/FR20(Y3) and HLA-A2/D76N-β2m/FR20(Y3) complexes, 
hereafter named  WT MHCI pI, MHC76 pI, WT MHCI pII and MHC76 pII, respectively. 
3.1.2 Thermal unfolding stabilities of MHCI species by CD 
Thermal unfolding measurements were performed in collaboration with Dr. Alberto 
Barbiroli (University of Milan) on WT MHCI and MHC76, both in complex with either 
peptide (pI) or peptide (pII), by monitoring the protein unfolding events with circular 
dichroism in the far UV region. The thermal unfolding curves of monomeric D76N β2m 
variant revealed a 9.8 ͦ C decrease in stability compared to the wt β2m, clearly highlighting 
different thermal stabilities for the two monomeric variants (see Fig. 8A); the  WT MHCI and 
MHC76, presenting the same peptide, display very similar thermal stabilities (Fig. 8B). The 
only observable difference between WT MHCI and MHC76, as expected, was due to the 
nature of the bound peptide used for preparation of MHCI species;  WT MHCI and MHC76 
associated with peptide (pI) were approx. 6.4 ͦ C more stable than the  WT MHCI and MHC76 
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with peptide (pII). The results suggest that, under these conditions, the D76N mutation does 
not affect the overall thermal stability of the assembled MHCI (see Fig. 8 and the included 
Table for Tm values).  
 
 
Figure 8. Overall thermodynamic stability of the different molecular species considered as determined by 
circular dichroism. Variation of far-UV CD signal as a function of temperature: (A) thermal unfolding of 
monomeric wt and D76N β2m monitored at 202 nm; (B) thermal unfolding of  WT MHCI and MHC76 with 
either pI or pII monitored at 218 nm. Table: melting temperatures for monomeric proteins and their assemblies 
as assessed using CD curves. 
3.1.3 Comparative analysis of MHC76 pI and WT MHCI pI crystal structures 
The potential structural effects induced by the Asp76 to Asn mutation on MHCI were 
assessed by analysis of the crystal structures of MHC76 (pI) in comparison with WT MHCI 
(pI), which were determined at 2.65 Å and 3.1 Å resolutions, respectively. The MHC76 and 
WT MHCI molecules were crystallized in the same orthorhombic space group P212121. The 
asymmetric unit contained fourteen MHCI moieties, arranged in two juxtaposed heptameric 
rings (Fig. 9A), a previously unreported packing for MHC crystal structures, containing 69% 
solvent content. A cartoon representation of the assembled MHC76 14-meric ring together 
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with one MHCI complex and the mutated D76N residue region in the protein is shown in Fig. 
9. 
 
 
Figure  9. Comparative analysis of MHC76 pI and  WT MHCI pI crystal structures. 
Ribbon representation of the MHC76 pI assembly in asymmetric unit. The fourteen MHCI molecules are 
organised in two juxtaposed heptameric rings: MHCI units from the front ring are differently coloured; those in 
the back are grey. (B), Ribbon representation of one MHC76 unit structure. The D76N mutation site on β2m is 
presented as a sticks model. The heavy chain, light chain and the bound nonapeptide are in blue, magenta, and 
green, respectively. (C) Stereo representation of the β2m EF-loop from the MHC76 structure (magenta), from  
WT MHCI (yellow) and from the monomeric D76N β2m (green). 
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In both crystal structures, the electron density is of excellent quality for all the 
fourteen MHCI units, except for the 87-91 residue stretch in all fourteen heavy chains of 
MHCI molecules. Data collection and refinement statistics for MHC76 and WT MHCI are 
shown in Table I. The fourteen MHC76 molecules in the asymmetric unit show negligible 
structural differences with an average root mean square deviation (r.m.s.d) of 0.29 Å/374 Cα 
atoms. 
Table I. Data collection and refinement statistics for WT MHCI and MHC76. 
Values in parenthesis are for the highest resolution shell. 
       Structure (PDB entry) 
  WT MHCI (4L29)   MHC76 (4L3C) 
    Data collection   
Beam line    BM-14 (ESRF)   ID14-4 (ESRF)   
Space Group    Orthorhombic P212121   Orthorhombic P212121 
Unit cell constants (Å)    a =101.5 b =313.3 c =314.4  a =102.1 b =314.5 c =316.2 
Solvent content (%)    69.0    69.5   
Resolution (Å)    53.88 - 3.10 (3.27 - 3.10)  70.63 - 2.65 (2.79 - 2.65)  
Rmerge a(%)    19.2 (101.5)   16.8 (90.5)    
I/sig(I)    9.3 (2.2)    6.8 (1.9)    
Completeness (%)   100.0 (100.0)   99.7 (99.7)   
Redundancy    5.8 (5.5)    5.3 (5.4)    
Unique reflections   182,537 (26405)   293,400 (42513)   
    Rifinement 
Rwork b(%)    17.06    19.91    
Rfree b(%)    20.05    21.83    
Number of atoms    44,629    44,738    
Ramachandran plot 
Most favored region   5073 (95.61%)    5059 (95.34%)   
Allowed region    233   (4.39%)   247   (4.66%)   
Outliers    0       (0.00%)   0       (0%)    
a R merge = ∑hkl Ihkl - < Ihkl > | / ∑hkl  Ihkl  where I is the observed intensity and < I > is the average intensity 
b R work =∑hklFo-Fc | / ∑hklFo for all data except 5% which were used for Rfree calculation. 
The MHC76 structure matched closely to the WT MHCI structure as well as to 
previously reported MHCI structure (pdb code: 1S9W) with a r.m.s.d of about 0.5 Å and 0.63 
Å, calculated over all the Cα atoms of the assembled complex, respectively. The D76N 
mutation site is located in the β2m EF-loop that is far from the heavy chain contact site (Fig. 
9B); accordingly, no major structural effects induced by the D76N mutation are observed at 
the heavy/light chain interface region. The β2m EF-loop within the MHC76 structure 
superposes well with the corresponding region of WT MHCI structures, as well as with the 
EF-loop of monomeric wt β2m (Fig. 9C). A 1.5 Å shift of Tyr78 towards Asn76, which was 
previously observed in the crystal structure of the monomeric D76N variant at 1.40 Å 
resolution (89), is not detected in the MHC76 structure (Fig. 9C), perhaps as a result of the 
lower resolution allowed by the MHC76 crystals.  
Overall, the crystal structure of MHC76 does not appear to be affected by the D76N 
mutation on the light chain β2m; globally and locally it closely matches the 3D structures of 
WT MHCI. Furthermore, it is worth noting that residue 76 is not involved in any crystal 
contact with symmetry-related molecules within the crystal packing. 
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3.1.4 Relative stabilities of MHCI species by Mass Spectrometry 
 Nano-ESI-MS analyses for all prepared MHCI species (WT MHCI pI, MHC76 pI, WT 
MHCI pII and MHC76 pII), under various native and denaturing conditions, were carried out 
by our collaborators (group of Prof. Rita Grandori) at the University of Milano-Bicocca, to 
probe any potential effect of the D76N mutation on stoichiometry, conformational states, 
relative stabilities and dissociation patterns of the complex. These analyses did not highlight 
any effect mediated by the D76N mutation on MHCI stability or internal hierarchy of the 
complex; the only observable effect was caused by the two different peptides used in the 
preparation of four MHCI species, as expected.  
3.1.5 Dynamic studies of β2m species by limited proteolysis 
 The flexibility and dynamics of WT and D76N β2m variants, both in their free-forms 
and assembled within MHCI molecules were studied by limited proteolysis by our 
collaborators at University of Pavia (Prof. Vittorio Bellotti’s group). The results revealed that 
the free form of D76N β2m was more prone to proteolytic digestion than the wt β2m; On the 
contrary, the assembled forms of the two β2m species within MHCI molecules (MHC76 and 
WT MHCI) were fully protected from proteolytic digestion, suggesting that the MHCI heavy 
chain plays a remarkably protective role on both β2m variants. 
3.1.6 In Vivo studies of D76N β2m variant  
 A transgenic mice expressing the amyloidogenic D76N β2m variant was created by our 
collaborators at University college London. The D76N variant was localized on the cell 
surface in assembled form within the MHCI molecules, providing further evidence that the 
D76N variant escapes cellular quality control mechanisms, and is consistent with the in vitro 
observations that the assembly of β2m within the MHCI masks its intrinsic misfolding 
propensity.  
(The detailed descriptions of the last three experiments can be found in the corresponding 
paper, in part II of this Thesis: Halabelian et al. (2014) J. Biol. Chem. 289, 3318-27). 
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3.2 A covalent homodimer to probe early oligomers along amyloid aggregation 
3.2.1 Recombinant S33C variant β2m homodimers 
β2m oligomeric species that generate early along fibril formation in DRA are 
responsible for cellular cytotoxicity. An anti-parallel DD strand interface was observed in 
several previous β2m variants, suggesting this as a favorable interaction site in 
oligomerisation. In order to study the role of the DD interface in β2m oligomers, we mutated 
Ser33 to Cys, and created the covalently-linked β2m homodimers that would interact via 
similar DD strand interface previously observed; the two facing Ser33 residues at DD strand 
interface in previous structures of β2m variants (pdb codes: 3TM6, 3TLR, 3CIQ) were found 
to fall at suitable distance to be mutated to Cys, yielding a disulphide-bonded β2m 
homodimer, without disrupting or straining the stereochemical properties of DD interface.  
The S33C β2m variant was expressed as inclusion bodies, purified under denaturating 
conditions, and then refolded according to our standard protocol (94). In our previous studies, 
formation of an intermolecular S-S bridge in other β2m homodimers was achieved through an 
additional dimerization step at the end of the purification, which required incubating the 
mutants at high protein concentration (5 mg/mL-1) in the presence of oxidizing agents (H2O2) 
(94). Conversely, a S-S bonded dimeric S33C species was abundantly present already during 
the protein refolding stage, suggesting that the DD strand interface is a favorable interaction 
site to juxtapose transient dimeric species during the β2m refolding process under these 
conditions. The covalent dimeric species of S33C β2m variant will be named hereafter 
DimC33. 
3.2.2 Overall Thermodynamic stability of DimC33 by CD 
Thermal unfolding stabilities of DimC33 and wt β2m, monitored by circular 
dichroism at Far-UV, indicates that DimC33 unfolds according to a simple sigmoidal curve, 
displaying a very similar Tm value compared to the wt protein (TmDimC33 60.2°C; Tmwt 
62.4°C), (Fig. 10A). Then, Far-UV spectra of DimC33 and of wt β2m were measured under 
three different solvent conditions: under native conditions in phosphate buffer, under 
denaturing conditions in 10% and 20% 2,2,2,-Trifluoroethanol (TFE). The results showed the 
maintenance of a native secondary structure content in phosphate buffer, as well as in 10% 
TFE conditions, for both wt and DimC33 molecules; on the contrary, for the 20% TFE 
conditions the wt β2m and DimC33 fold appeared severely affected, (Fig. 10B). Thus, the 
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spectroscopic data suggest that the S33C mutation and the generated disulfide-bonded dimer 
do not alter the β2m thermodynamic stability or its overall fold. 
 
Figure 10. Thermodynamic stability and Far-UV spectra analysis by circular dichroism. (A) Temperature 
ramps for DimC33 in red and wt β2m in black, monitored at 202 nm, temperature slope 50 °C/h. The melting 
temperature I values for DimC33 and wt β2m are shown in the graph. (B) Far-UV spectra for DimC33 and wt 
β2m in a buffer containing 100 mM sodium chloride, 50 mM sodium phosphate buffer pH 7.4, recorded at three 
conditions: No TFE (black curves); in addition of 10% (v/v) TFE (red curves); and 20% (v/v) TFE (blue curves). 
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3.2.3 Aggregation kinetics of DimC33 and wt ß2m in vitro 
The kinetics of DimC33 aggregation was assessed in vitro under physiological pH 
conditions (pH 7.4), and in the absence of any pre-fibrillar seeds (which is strictly necessary 
for wt β2m aggregation under the same conditions). In 20% (v/v) TFE, a 1 mg mL-1 DimC33 
aggregated aggressively, without an aggregation lag phase, reaching equilibrium within the 
first 4 hours, and triggering high ThT fluorescence binding signal; under the same conditions 
wt β2m remained soluble (Fig. 11A). Interestingly, in 10% (v/v) TFE—where DimC33 and 
wt β2m display CD spectra indicative of native secondary structures—a 5 mg mL-1 solution 
of DimC33 also aggregated triggering high ThT binding signal. 
 
Figure 11. DimC33: fibrillogenesis at pH7.4. (A) Kinetics of DimC33 fibril formation in100mM NaCl, 50 mM 
Sodium phosphate buffer (pH 7.4) at 37°C incubation for two weeks, monitored by measuring ThT fluorescence 
signal at time (hours) 0, 4, 48, 96, 144, 216, 312. Four samples were screened: DimC33_20%TFE (5 mg mL-1 
protein in 20% TFE); DimC33_10%TFE (1 mg mL-1 protein in 10% TFE); DimC33/wtβ2m mixture in 1:3 ratio 
(1 mg mL-1 protein mixture in 20% TFE); and wtβ2m_20%TFE as a control model (1 mg mL-1 protein in 20% 
TFE). Values represent the average of three independent experiments and error bars represent SD. (B) DimC33 
aggregation inhibition analysis monitored by ThT fluorescence signal after one week of incubation at 37°C, 
using the same aggregation condition as DimC33_20%TFE in three conditions; No Doxycycline (control 
model), in the presence of 100 µM and 400µM Doxycycline. Values represent the average of three independent 
experiments and error bars represent SD. 
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The inhibitory effect of doxycycline on DimC33 aggregation—doxycycline is well-
known to inhibit wt β2m aggregation with an overall IC50 value of ~47 µM (95)—was 
assessed under the same DimC33_20%TFE aggregation condition, in the presence of 100 or 
400µM doxycycline, and measuring the ThT binding signal after one week of incubation at 
37°C. While, 100µM doxycycline was sufficient to inhibit DimC33 aggregation by approx. 
85% compared with the control model of DimC33_20%TFE in the absence of any 
doxycycline; 400 µM doxycycline completely blocked DimC33 aggregation (see Fig. 11B). 
3.2.4 X-ray crystal structures of DimC33  
Two crystal structures of DimC33, displaying different space groups and crystal 
packings, were determined at 1.4Å and 1.9Å resolution, hereafter named DimC33_high and 
DimC33_low, respectively; additionally a crystal structure of DimC33 in complex with 
Thioflavin-T (ThT), was determined at 2.8Å resolution, and named DimC33_ThT. Data 
collection and refinement statistics for DimC33 crystal structures are shown in Table II.  
Table II.  Data collection and refinement statistics for DimC33. 
Values in parenthesis are for the highest resolution shell. 
      Structure (PDB entry) 
DimC33-Low (4R9H) DimC33-High (4RAH) DimC33-ThT (4RA3) 
    Data collection   
Beam line  ID21-3 (ESRF)  ID21-3 (ESRF)  PETRA III, P13 (MX1) 
Space Group  P4122   C2221   P3221 
Unit cell constants (Å)  a=68.84 b=68.84 c=200.04 a=32.35 b=47.70 c=119.65 a=80.04 b=80.04 c=177.70 
Resolution (Å)  65.09 - 1.90 (2.00 - 1.90) 29.91 - 1.40 (1.42 - 1.40) 59.23 - 2.80 (2.95 -2.80) 
Rmerge a(%)  10.9 (94.0)   6.5 (49.5)   5.9 (113.9)   
I/sig(I)  12.4 (2.2)   10.9 (1.9)   21.4 (2.0) 
Completeness (%) 99.9 (99.6)   98.7 (86.6)   100.0 (100.0) 
Redundancy  8.9 (8.3)   4.5 (3.4)   9.6 (10.0) 
Unique reflections 38985 (5533)  18491 (787)  16940 (2432) 
    Refinement 
Rwork b(%)  21.17   16.62   15.08 
Rfree b(%)  24.73   20.94   18.12   
Number of atoms  3480   1021   3407 
Average B, all atoms (Å2) 42.0   17.0   111.0 
Ramachandran plot 
Most favored region 375 (98.68%)   86 (100%)   367 (94.83%) 
Allowed region  4     (1.05%)  0   (0%)   20   (5.17%) 
Outliers  1     (0.26%)  0   (0%)   0   (0%) 
a R merge = ∑hkl  Ihkl - < Ihkl > |/∑hkl  Ihkl  where I is the observed intensity and < I > is the average intensity. 
b R work = ∑hklFo-Fc |/ ∑hklFo for all data except 5% which were used for Rfree calculation. 
The electron density in all three crystal structures is of excellent quality and all 
molecules are completely traceable. Overall, no major structural effects were observed on the 
β2m fold as a result of the S33C mutation, neither locally nor globally, in all DimC33 
structures (Fig. 12A, B). The monomeric components of DimC33 most closely match the 
assembled conformation of β2m within MHCI molecule, showing an average r.m.s.d value of 
0.90 Å over all the 98 Cα atoms (Table III). The only noticeable difference is in the DE-loop 
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region (residues 57-60) where Trp60 participates in stacking interactions with Phe56 of the 
same chain and with His51 and Tyr66 of the opposing chain within DD dimer interface; the 
rotation of Tyr63 side chain of about 90 degrees is also observed as a result of the DE-loop 
conformational change (see Fig 12C).  
 
Figure 12. Crystal structure of DimC33 and DD strand interface. (A) Ribbon model of a monomeric of 
DimC33 (blue) superposed on the structure of wt β2m (green). β-strands are labeled according to standard 
nomenclature, Cys33 is shown in sticks. (B) A zoomed model into DD interface of four superposed crystal 
structures of DimC33_ThT (in green), hexameric structure of H13F β2m in magenta, DimC50 in cyan and 
DimC20 in yellow, showing some of the amino acid side chains located near DD interface as sticks model. (C) 
One moleculce of DimC33_ThT (pdb code: 4RA3) in green superposed with three reference models: hexameric 
structure of H13F β2m in magenta (pdb code:3CIQ), DimC50 structure in cyan (pdb code: 3TM6), and DimC20 
structure in yellow (pdb code: 3TLR). (D) Stereo view of the DD strand interface formed by the facing 
molecules as observed in the structure of DimC33_high. The main residues involved in the interface are labeled. 
The overall organization of β2m chains within the covalent dimer, in all three DimC33 
structures, was well conserved showing averaged r.m.s.d values of 0.57Å/195Cα and 
1.17Å/195Cα for DimC33_high superposed on DimC33_ThT, and DimC33_low, 
respectively. The superposition of DimC33 structures with previously reported β2m variants 
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(pdb codes: 3TLR, 3TM6, 3CIQ) show similar arrangement of β2m molecules that are 
associated through formation of the DD strands interface (Fig. 12C and Table III).  
Table III. The SSM superimposed RMS deviations for DimC33 structures with reference models 
DimC20, DimC50, hexameric H13F β2m and wt β2m. 
DimC20  DimC50 H13F β2m    wt β2m 
(3TLR)  (3TM6)  (3CIQ)  (1JF1) 
DimC33-High(Mono) 0,62/99 Cα  0,59/98 Cα 1,05/97 Cα 0,97/98 Cα 
DimC33-High  2,41/182Cα  2,10/192Cα 1,11/192Cα     --- 
 
The covalent DD strand interface is structurally well conserved in all three DimC33 
structures, where it maintains the same contact surface area of ~ 560 Å2: the main regions 
involved in the association interface are the BC-loop (residues 31-37), part of D-strand 
(residues 51-57), the DE-loop (residues 57-60), Phe62 and part of E-strand (residues 64 and 
66), which is in agreement with the previous structures of β2m variants (pdb codes: 3TLR, 
3TM6, 3CIQ) (Fig. 12B,D). The above data indicate that the S33C mutation and the resulting 
disulfide-linked homodimer maintain native β2m fold, and that the created DD strand 
interface exhibits very similar intermolecular interactions compared to previous crystal 
structures of  monomeric β2m variants (pdb codes: 3TLR, 3TM6, 3CIQ) (Fig. 12B, D). 
3.2.5 The DimC33_ThT complex and the ABDE sheet 
The crystal structure of DimC33_ThT was obtained in the presence of 5mM ThT; the 
asymmetric unit (AU) contained five ThT molecules anchored in two different binding sites 
formed between two interacting DimC33 molecules (Fig. 13A).  
In the crystal structure of DimC33_ThT, β2m molecules belonging to different 
homodimers interact exclusively via two sets of  ABDE β-sheet interfaces, creating two 
distinct ThT binding sites: on one hand, four ThT molecules are wedged between the ABDE 
β-sheets of two facing β2m molecules (4ThT site) by establishing mutual π-π stacking 
interactions, and with Tyr10 and Tyr63 of two facing β2m molecules (Fig. 13C); Tyr26 
residues from both β2m molecules also help accommodate the ThT hydrophobic rings. On the 
other, only one ThT molecule is sandwiched between two Tyr10 residues in the ABDE sheets 
interface of two facing β2m molecules (Fig. 13B); Tyr26 and Pro14 from both molecules 
establish van der Waals contacts with ThT. The binding of ThT does not induce any 
conformational adjustments in the β2m fold, nor in the DimC33 assembly. 
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Figure 13. Crystal structures of DimC33_ThT and DimC33_low. (A) Cartoon representation of DimC33 
assembly in crystal structure of DimC33_ThT. The three DimC33 colored in cyan, green and magenta. Two ThT 
binding sites are visible: on the left the four ThT molecules (4ThT site) are colored in slate-blue; while on the 
right side, one ThT molecule (1ThT site) is colored in red. (B) A zoomed representation into 1ThT site showing 
ThT molecule sandwiched between the ABDE sheets of the two adjacent DimC33. (C) A zoomed representation 
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into 4ThT site where four molecules of ThT in slate-blue are stacked between two facing ABDE sheets. (D) 
Ribbon represenation of ABDE interface as found in the hexameric structure of H13F β2m (pdb code: 3CIQ). 
(E) Ribbon represenation of ABDE interface present in the DimC33_low (pdb code : 4R9H). 
The two ThT binding sites share common similarities in the mode of β2m/ThT 
interaction: in both cases, three aromatic residues (Tyr10, Tyr26 and Tyr63) play a key role in 
creating the ABDE sheet interface (the ThT binding cavity) built by two facing β2m chains; 
in particular, Tyr10 establishes direct stacking interactions with ThT molecules at both 
interaction sites. 
A similar ABDE β-sheet interface is also observed in the absence of ThT: in the 
DimC33_low structure and in the hexameric β2m structure (50), highly hydrophobic ABDE 
interfaces are formed with a surface area of 805 and 970 Å2, respectively. Although the two 
facing β2m molecules are differently oriented in the two structures, the ABDE interfaces are 
highly comparable where the aromatic residues of Tyr10, Tyr26 and Tyr63 form the 
hydrophobic core interface (see Fig. 13D, E). Thus, the four ABDE interfaces found in 1ThT 
and 4ThT sites of DimC33_ThT, in DimC33_low and in the hexameric structure of H13F 
β2m (pdb code:3CIQ) strongly point at this sheet as privileged site for interaction during 
oligomer formation.  
 All the experiments and results presented under the Section 3.2 are summarized in a 
manuscript that is under submission at the time of presenting this Thesis work, and can be 
found in Part III of this Thesis: Halabelian et al. “A covalent homodimer to probe the first 
oligomers along amyloid aggregation” (2014). 
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4. CONCLUSIONS AND FUTURE PERSPECTIVES 
4.1 MHCI: the Trojan horse for secretion of amyloidogenic β2m 
Unlike DRA, which is caused by elevated serum concentration of free circulating wt 
β2m in patients with kidney failure, the hereditary systemic amyloidosis is caused by an 
extremely amylodogenic D76N β2m variant that aggregates in a completely physiological 
serum concentration and functional kidney conditions (89). Although human cells adopt 
sophisticated and potent systems to control and eliminate partially folded or misfolded 
proteins (96), the D76N β2m variant manages to escape the cellular quality control systems, 
reaching the extracellular blood circulation where it aggregates by forming huge amyloid 
deposits (89). It is known that once β2m is synthesized in the cell, it is promptly transported 
by specific transporter proteins into the Golgi apparatus, where it is assembled into a mature 
MHCI molecule and transported to the cell surface (24). In this way, the amyloidogenic 
D76N β2m variant has only a very brief intracellular existence as an isolated chain. 
Our data show that despite the monomeric D76N β2m variant is highly unstable and 
aggregation prone compared to wt β2m, they both have similar structures, stability and 
dynamics once assembled within the MHCI molecules. In other words, the MHCI acts as a 
chaperone to stabilize the D76N β2m variant and protect the cell from D76N β2m 
aggregation. However, in fulfilling such a role, the MHCI molecules mask and hide the 
amyloidogenic properties of the D76N variant from the UPR and other cellular quality control 
systems, leading to the secure transfer to the cellular surface, where during its normal 
turnover, the MHCI molecules dissociate, releasing β2m and the carried antigen in the 
extracellular environment. Hence, MHCI molecules act as a Trojan horse for translocation of 
the D76N β2m variant outside the cell, where the D76N variant aggregates and causes human 
pathologies. 
In this study, we show that the amyloidogenic D76N β2m variant is efficiently 
stabilized and maintained in its normal structural and physiological properties once assembled 
within MHCI molecules. Such finding may open new therapeutic approaches for targeting the 
D76N variant by specific antibodies (77), or small molecules (84), to stabilize and inhibit its 
aggregation. Finally, the mouse model expressing the D76N variant will serve as a 
development tool for future studies on systemic amyloidosis, and for testing new therapeutic 
approaches against D76N β2m dependent systemic amyloidosis. 
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4.2 A covalent homodimer to probe early oligomers along amyloid aggregation 
 Oligomeric species generated along the formation of amyloid fibrils are shown to be 
responsible for cellular cytotoxicity in amyloid-related diseases (1). Elucidating the interfaces 
involved in oligomerization, at molecular level, is of paramount importance for a clear 
understanding of the aggregation processes that lead to the design/discovery of potential drug 
targets for therapeutic intervention. In this study, we used β2m as a model to study the 
interfaces involved in the formation of toxic oligomeric species in DRA. We designed a 
covalently-linked homodimers of S33C β2m variant to interact via anti-parallel DD strand 
interface; such interface was previously reported as a favorable interaction site in three 
independent crystal structures of β2m variants (50, 94).  
Our results demonstrate that DimC33 is highly amyloidogenic compared to wt β2m, 
that aggregates in the absence of amyloid seeds in in vitro conditions, even though its 
thermodynamic stability and its structure are virtually identical to those of the wt protein, 
suggesting that the DD interface could represent the first interaction site favoring 
oligomerisation and aggregation. Furthermore, DimC33 also aggregates in 10% 2,2,2,-
Trifluoroethanol—a condition where β2m fold is still native—indicating that DimC33 can 
spontaneously form the on-pathway oligomeric species required for fibrillogenesis (Fig. 
10B). Similarly to wt β2m (84), DimC33 aggregation is inhibited by comparable amounts of 
doxycycline, suggesting that similar interfaces are involved in both DimC33 and wt β2m 
oligomerisation and aggregation mechanisms.  
Moreover, DimC33 molecules bind Thioflavin-T (ThT)—which is the most widely 
used fluorescent dye for selective detection of cross-β structures in amyloid fibrils—at an 
intermolecular interface formed by the ABDE β-sheets of two facing β2m chains belonging to 
different DimC33 moeties, which provides further evidence on oligomeric interaction sites in 
β2m aggregation and ThT binding. Only one oligomeric β2m structure that binds ThT has 
been reported so far (pdb code: 3MZT), which presents severe technical issues (72). 
Therefore, the DimC33_ThT structure reported here, adds substantial information on the 
molecular mechanisms of ThT binding to amyloidogenic proteins. Given the fact that many 
small molecule inhibitors of amyloids share common chemical and structural characteristics 
with the ThT molecule (88), then the ThT binding site shown in the crystal structure of 
DimC33_ThT provides, for the first time, a potential site for targeting drugs against the toxic 
oligomers. 
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Finally, an extended ABDE interface of two facing β2m molecules was also observed 
also in the absence of ThT, in our crystal structure of DimC33_low (Fig. 13D) and in the 
hexameric β2m structure (Fig. 13E) reported earlier (97), suggesting that the ABDE β-sheet 
interface could represent a second interface involved in β2m oligomerization. The structural 
and biophysical analysis of DimC33 reported here give strong clues on how oligomerization 
may proceed during aggregation: (i) the first dimeric species would be built across the DD 
strand interface, (ii) the ABDE β-sheets of β2m homodimers will then serve as a second 
sticky interface leading to the formation of various toxic oligomeric species that would serve 
as building blocks for amyloid fibril formation. 
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Abstract 
Human Beta2-microglobulin (β2m) is a 99-residue protein responsible for 
Dialysis-Related Amyloidosis in patients undergoing long-term dialysis linked to 
kidney failure. The mechanism underlying β2m aggregation into amyloid is only 
broadly understood; in particular, which protein regions are involved in β2m 
oligomerization is still matter of debate. Previous evidences suggest that β2m D 
strand plays a role in initial aggregation. An anti-parallel intermolecular interaction 
between D strands of facing β2m molecules was observed in several crystal 
structures, suggesting that that such interface may be relevant for β2m dimerization. 
In this study, by mutating Ser33 to Cys, and assembling the disulphide-stabilised β2m 
homodimeric species (DimC33), we constrained two β2m molecules to interact 
constitutively through such DD strand interface. Although the isolated DimC33 
displays stability and behavior similar to wt β2m under native conditions, it shows 
enhanced amyloid aggregation propensity relative to wt β2m, both under denaturating 
and native-like conditions. To explore the molecular bases of such enhanced 
aggregation property, three distinct crystal structures of DimC33 were determined. 
Based on crystal packing considerations, we suggest that dimerization through the DD 
interface is instrumental for enhancing DimC33 aggregation propensity. This 
observation bears implications for wt β2m oligomerization. Furthermore, the crystal 
structure of DimC33 in its complex with Thioflavine-T (ThT), a well-known amyloid-
specific dye, pinpoints a second interface, which likely participates in the first steps of 
β2m aggregation. 
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Introduction  
Amyloidogenesis is a complex and non-homogeneous process whereby, 
during the nucleation phase, monomeric protein molecules start to associate, firstly 
yielding oligomeric species that eventually lead to mature amyloid fibrils {Morris, 
2009 #8}. A growing set of evidences indicates that in amyloid-dependent 
degenerative diseases the early oligomers are the most cytotoxic species {Chiti, 2006 
#210}. It is therefore particularly relevant to shed light on the molecular bases of 
oligomer assembly to design strategies not only against amyloid deposits, but also 
specifically to inhibit the formation of the cytotoxic species. Nevertheless, since the 
oligomers are transient species in equilibrium with higher/lower molecular weight 
aggregates, only in a few cases they have been successfully isolated {Campioni, 2010 
#209}. Even when isolated in vitro, typically the oligomers are too heterogeneous and 
unstable for high-resolution structural investigations. Accordingly, a description of 
oligomers at the molecular level is generally lacking, most evidences on oligomer 
structure being obtained though spectroscopic techniques or microscopy 
investigations {Bemporad, 2012 #216}. 
In order to elucidate the structural bases of oligomer formation we focused on 
the amyloidogenic protein beta-2 microglobulin (β2m), whose native fold is 
structurally well characterized and amyloid formation in vitro has been thoroughly 
described {Platt, 2009 #110}. β2m is a 99-residue globular protein with a typical 
immunoglobulin-like fold, composed of seven β-strands arranged in two β-sheets, 
named ABDE and CFG, respectively, according to standard nomenclature of the 
composing β-strands (Fig. 1a); the two sheets are internally linked by a disulphide 
bond {Bjorkman, 1987 #11}. β2m is an aggregation-prone protein responsible for two 
types of amyloid-related diseases: the wild type (wt) protein is responsible for 
Dialysis-Related Amyloidosis (DRA) {Floege, 1996 #87}, while a severe hereditary 
systemic amyloidosis is linked to the pathological β2m D76N mutant {Valleix, 2012 
#43}. Physiologically, β2m is degraded in the kidneys; DRA patients typically suffer 
from kidney dysfunction that results in β2m accumulation in the serum following 
dialysis. Over the years, β2m aggregates in the skeletal joints, bones and muscles, 
resulting in bone fragility and movement impairment {Gejyo, 1985 #13}.  
Wt β2m aggregation propensity has been extensively studied in the last 
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decades, although one important limitation for the study of β2m aggregation is that 
the wt protein in vitro is stable for months under native conditions. Accordingly, all 
wt β2m aggregation protocols are based on conditions under which the protein is 
completely or partially unfolded (low pH, denaturants such 2,2,2-trifluoroethanol 
(TFE), or sodium dodecylsulphate). Moreover, in order to trigger aggregation, the 
addition of amyloid-fibril seeds to the reaction mixture is necessary {Jahn, 2008 
#211}. Thus, such aggregation protocols may not match the natural β2m 
oligomerisation occurring in patients. In fact, given the intrinsic β2m stability, the 
protein is unlikely to be largely unfolded before amyloid deposition takes place in 
vivo; moreover, the addition of seeds allows to study fibril growth, but the seeds fully 
abolish the key early process of oligomer formation. 
Several independent reports suggest that the first oligomeric species formed 
during β2m aggregation is an elongated dimer: extended oligomers have been 
observed by mass-spectrometry, and an elongated dimer was proposed to be the 
starting species in β2m oligomerization {Karamanos, 2014 #208;Rennella, 2013 
#213;Smith, 2010 #212;White, 2009 #117}. Several studies aimed at uncovering the 
structure of β2m oligomers during aggregation have been reported. In particular, 
Eisenberg and coworkers proposed a domain-swapped covalent dimer {Liu, 2011 
#214}: this species is amyloidogenic, however in ex vivo samples there is no evidence 
of comparable covalent oligomers. Miranker and coworkers reported the crystal 
structure of a hexameric form of the H13F β2m mutant {Calabrese M. F., 2008 #46}, 
formed under aggregating conditions. Such hexameric assembly is however not 
amyloidogenic, therefore, at least to some extent, it may represents an off-pathway 
oligomer {Calabrese, 2008 #75}.  
We recently tested a different approach to the study of β2m oligomer 
formation. Three single Cys mutations were inserted in different β2m surface regions, 
and disulphide-linked covalent homodimers were prepared. The rationale was that a 
covalent bond between two β2m molecules acts as a constraint for the architecture of 
the dimer, which can be aggregation permissive or non-permissive. The three 
homodimers were structurally and biophysically characterized {Colombo, 2012 
#207}. The crystal structures of DimC50 and DimC20 (i.e. β2m homodimeric species 
hosting intermolecular disulphide bridges between pairs of C50 and C20 engineered 
residues, respectively) showed that a common antiparallel interface between covalent 
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dimers (named the DD strand interface) was constantly present in their crystal 
packings. The DimC50 and DimC20 species proved to be amyloidogenic, could be 
crystallized, and assembled as (non-covalent) dimer of (covalent) dimers in solution. 
Notably the S-S bond location in the third engineered homodimer (DimC60) hampers 
the formation of the DD strand interface for steric reasons; thus, DimC60 was not 
amyloidogenic, purely dimeric in solution and not crystallizable. Based on such 
observations, the DD strand interface was proposed as a key association interface 
involved in the early stages of β2m association under native and non-native 
conditions {Colombo, 2012 #207}.  
The DD strand interface involves the apical region of two facing β2m 
molecules, in such a way that they give rise to a dimer associated through head to 
head interactions. The D-strands belonging to the facing molecules are antiparallel 
and the two β2m molecules involved display the same conformation and are well 
superposable. Within each β2m monomer the DD strand interface involves the D-
strand, the DE and BC loops, namely regions that have been reported as major players 
in β2m amyloid aggregation {Colombo, 2012 #207} (Fig. 1). Such intermolecular 
association interface had also been noted in the hexameric structure of the H13F β2m 
mutant {Calabrese, 2008 #75}. 
Following our previous approach, in the present study we engineered a β2m 
homodimer where the DD strand interface is specifically locked by a disulphide bond 
(linking the engineered C33 residues of two facing β2m molecules – DimC33). We 
speculated that analysis of such a covalently stabilized dimer should allow us to 
assess more directly the role played by association through the DD strand interface in 
β2m oligomerisation and amyloid formation. DimC33 has been characterized in 
solution and under aggregation conditions; moreover, we determined three different 
crystal structures of the covalent dimer, one of which hosts the DimC33 complex with 
Thioflavin (ThT), the hallmark fluorescence dye for amyloid aggregates. The data 
here reported show that a covalently stabilized DD strand interface facilitates β2m 
aggregation under denaturating but also under native-like conditions, highlighting 
DimC33 as the first model system to study β2m aggregation in vitro under native-like 
conditions. Our results recapitulate previous data indicating the DD strand interface as 
the first and favorite intermolecular contact region between β2m molecules under 
native or aggregating conditions. Furthermore, analysis of the crystal structure of 
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DimC33 in complex with ThT strongly points to a second β2m association interface 
that may be involved in amyloid aggregation. 
Results 
Recombinant S33C variant β2m homodimers 
In order to engineer a β2m covalent dimer displaying a locked DD strand 
interface, a detailed analysis of the crystal structures displaying such intermolecular 
association interface (pdb codes: 3TM6, 3TLR, 3CIQ) was performed, and the 
mutation of Ser33 to Cys was chosen based on the following rationale. Firstly, two 
Ser33 residues belonging to two facing β2m molecules (in the examined crystal 
structures) fall at a suitable distance to be mutated to Cys and yield a disulphide 
bridge without disrupting or altering the DD interface. Secondly, among the residues, 
which could satisfy the above conditions, a Ser residue was chosen because it is 
essentially isosteric with Cys.  
The S33C β2m variant was expressed and purified under denaturating 
conditions and then refolded, according to our standard protocols {Esposito, 2008 
#61}. In our previous study on covalent β2m homodimers, in order to promote the 
formation of covalent disulphide linked homodimers, an oxidation reaction proved 
necessary. To this purpose, after refolding, the monomeric β2m variants were 
incubated at high protein concentrations in the presence of H2O2 {Colombo M, 2012 
#47}. Conversely, in the case of the S33C β2m variant, a covalent dimeric species 
was abundantly present at the end of the purification, in the absence of further 
oxidation reactions. This finding implies that in solution under native conditions the 
DD interface is spontaneously formed by monomeric β2m molecules, resulting in the 
formation of the disulphide-stabilized dimeric species (DimC33). 
The stability of DimC33 in solution was assessed by circular dichroism. 
Thermal unfolding monitored by Far-UV indicates that, as for wt β2m, DimC33 
unfolds according to a simple sigmoidal curve and displays a Tm value close to that 
of the wt protein (TmDimC33 60.2 ±0.3°C; Tmwt 62.4±0.3°C) (Fig 2a). Then, Far-UV 
spectra of DimC33 and of wt β2m in phosphate buffer, in 10% and 20% TFE were 
collected, showing that native spectra are well superposable and that both proteins 
display a native secondary structure content in 10% TFE; conversely the β2m fold is 
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perturbed in 20% TFE (Fig. 2b). Thus, the spectroscopic data suggest that the 
engineered mutation and the achievement of a covalent dimeric state do not alter β2m 
thermodynamic stability or its overall fold in DimC33. 
Aggregation kinetics of DimC33 and wt ß2m in vitro 
We studied DimC33 aggregation propensity in vitro at physiological pH 
conditions (pH 7.4) in the absence of any pre-fibrillar seeds. In 20% (v/v) TFE, 
DimC33 at a final concentration of 1 mg mL-1 aggregates promptly without a lag 
phase, reaching equilibrium within the first 4 hours, and yielding a high ThT binding 
signal (Fig. 3a); under the same conditions wt β2m remains soluble and does not 
aggregate. Interestingly, in 10% (v/v) TFE—where DimC33 and wt β2m display CD 
spectra indicative of native-like conformations—a 5 mg mL-1 solution of DimC33 
also aggregated.  
Doxycycline is a known inhibitor of wt β2m aggregation {Giorgetti, 2010 
#137}. In order to assess doxycycline inhibitory effect on DimC33 aggregation, a 
DimC33 solution was tested for aggregation in the presence of 100µM and 400µM 
Doxycycline, in 20% TFE. A 100µM final concentration of Doxycycline was 
sufficient to block DimC33 aggregation by approximately 85%, compared with a 
DimC33_20%ThT control solution, whereas 400 µM Doxycycline completely 
inhibited DimC33 aggregation (Fig 3b). Such results are in keeping with previous 
data on wt protein reporting an IC50 of 47 µM for doxycycline as aggregation 
inhibitor {Giorgetti, 2010 #137}. 
X-ray crystal structures of DimC33  
In order to assess fine details of the molecular structure of DimC33, two 
crystal structures of DimC33 were determined at 1.9Å and 1.4Å resolution, hereafter 
named DimC33_low and DimC33_high, respectively; additionally a crystal structure 
of DimC33 in complex with ThT was determined at 2.8Å resolution, and named 
DimC33_ThT. Data collection and refinement statistics for the crystal structures are 
shown in Table I. 
The three crystal structures display three different space groups and crystal 
packings. The electron density is of excellent quality and all β2m molecules are 
completely traceable in all three structures. Overall, no major structural effects on the 
β2m fold are induced by the S33C mutation, either locally or globally, in all DimC33 
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structures, (Fig. 1b-c). The monomeric components of DimC33 most closely match 
the conformation of wt β2m as observed in its physiologic class I major 
histocompatibility complex (Table 2). The only noticeable difference occurs in the DE 
loop (residues 57-60) that displays a slightly modified conformation so that Trp60 
participates in stacking interactions with Phe56, of the same chain, and with His51 
and Tyr66 of the second chain within DimC33; the rotation of Tyr63 side chain of 
about 90 degrees is also observed (see Fig. 1b). 
The covalent DD strand interface is structurally well conserved in all three 
DimC33 structures, where it maintains the same contact surface of 560 Å2. The 
overall dimer organization is conserved (r.m.s.d. 0.57 Å/195 Cα, 1.17 Å/195 Cα, 
DimC33_high versus DimC33_ThT and versus DimC33_low, respectively); the main 
regions involved in the association interface are the BC loop (residues 31-37), the D 
strand (residues 51-57), the DE loop (residues 57-6), Phe62, the E strand (residues 64 
and 66), as observed in previous structures (Fig. 1b-d). The superposition of DimC33 
with previously reported β2m dimers, non-covalently associated through the DD 
strand interface, shows a very similar overall monomer-monomer orientation (Fig. 1c 
and Table 2) and conserved conformations for the residues involved (Fig. 1b-d and 
Table 2). All such data indicate that the S33C mutation minimally affects the β2m 
fold, and that the C33 – 33C disulphide covalently locks the DD strand interface with 
negligible structural effects compared to the previous crystal structures Fig. 1b-d. 
The DimC33 ThT complex and the ABDE sheet 
DimC33 was also crystallized in the presence of 5mM ThT. Intriguingly, the 
crystallographic analysis showed that five ThT molecules are hosted in the crystal 
asymmetric unit (AU), which contains one DimC33 moiety and two halves of a 
second one (i.e. two additional and independent β2m chains). As a result of crystal 
packing, β2m molecules belonging to independent DimC33 units interact via their 
ABDE β-sheets (Fig. 4a); however, two distinct ABDE interfaces can be 
distinguished. In one of these, four ThT molecules are wedged between the ABDE 
sheets of two facing β2m molecules (4ThT site); in the other, only one ThT molecule 
is sandwiched between two facing ABDE sheets (1ThT site) (Fig. 4a). In either case, 
binding of the ThT molecules does not induce any conformational adjustments in the 
β2m fold, or in the DimC33 assembly. At the 1ThT site, the ThT molecule is 
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sandwiched between Tyr10 residues from two facing β2m molecules; moreover, 
Tyr26 and Pro14 from both molecules establish van der Waals contacts with ThT 
(Fig. 4b). At the 4ThT site, the four ThT molecules are stacked on each other, and in 
stacking contacts with Tyr10 and Tyr65 of the β2m molecules defining the binding 
site. Tyr26 from both β2m molecules also help accommodate the ThT hydrophobic 
rings (Fig. 4c). 
In order to house one or four ThT molecules, the β2m chains, which belong to 
two distinct DimC33 units, are differently juxtaposed. In particular, the two β2m 
molecules defining the 4ThT site move about 20Å apart compared to the 1ThT site, to 
make room for the four ThT molecules. Thus, very limited direct interactions connect 
the two β2m molecules at the 4ThT site, whereas more direct protein-protein contacts 
take place at the 1ThT site. Despite such translational adjustments, the two ThT sites 
maintain very similar structural arrangements. The relative orientation of the two β2m 
chains defining the ThT sites is comparable, and the protein regions involved in ThT 
binding are conserved. More specifically, Tyr10, Tyr26 and Tyr63, the three central 
residues in the ABDE interface, cross diagonally the sheet and confer substantial 
surface hydrophobicity (Fig. 4). In particular, at both ThT sites Tyr10 establishes 
direct stacking interactions with ThT molecules, even though the ThT molecules do 
not share the same orientation in the two sites. 
It must be noted that wide intermolecular packing contacts through the ABDE 
sheet are established also in the absence of ThT. In the structure of DimC33_low 
(present work) and in the hexameric H13F mutant {Calabrese, 2008 #75}, highly 
hydrophobic association interfaces are built via facing ABDE sheets (surface areas of 
805 and 970 Å2, respectively). Although such two ABDE assemblies are not 
superposable, the two interfaces are structurally similar and residues Tyr10, Tyr26 
and Tyr63 are clustered in their hydrophobic cores (see Fig. 4D,E).  
In summary, in the four ABDE packing interfaces examined (the 1ThT and 
4ThT sites, and the ABDE interfaces in DimC33_low and in hexameric β2m) the 
orientations of each β2m monomeric chain may vary, the distances between protein 
chains are somewhat different, and the packing interactions between the ABDE sheets 
can be direct or mediated through ThT molecules. However, the overall conservation 
of protein-protein interaction surface, the binding of ThT, the size of the surfaces, the 
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structural data and the marked hydrophobicity of the residues involved, all point at 
this sheet as a favored site for β2m association during oligomer formation. 
Discussion 
Elucidating the structure and the underlying interactions of on-pathway 
oligomers that lead to amyloid aggregation is a crucial and challenging task, since it is 
well established that oligomers are the most cytotoxic species in amyloid-related 
diseases {Chiti, 2006 #210}. A structural characterization of the first steps of 
oligomer formation would be key for a deeper understanding of the aggregation 
process, and potentially for the design of inhibitors hampering the oligomerisation 
process, hence in principle abolishing cytotoxicity.  
We selected β2m as a model of amyloid aggregation, since the protein has 
been extensively characterized, and several structural determinants of β2m 
amyloidogenicity have been uncovered {Platt, 2009 #110}. In order to shed light on 
the intermolecular interactions that drive the first steps of aggregation, a disulphide-
linked β2m homodimer was designed according to a previously proposed strategy 
{Colombo, 2012 #207}. The engineered S-S bond was positioned on the protein 
surface in order to juxtapose two β2m monomers along the DD strand interface, 
which was observed as an intermolecular association region in three previous 
independent β2m crystal structures {Calabrese, 2008 #75;Colombo, 2012 #207}. The 
mutation Ser33 to Cys is structurally conservative, and designed to bring together two 
β2m molecules based on structural information from the previously observed 
intermolecular recognition through the DD strand interface, without altering its 
structure. From the in vitro biophysical data, and from the crystallographic analysis 
here reported, all evidences suggest that the mutation and the engineered disulphide 
do not affect β2m properties to a significant extent: thermodynamic stability, 
secondary structure content in aqueous buffer and in TFE, and the comparison of 
DimC33 crystal structures with previous wt β2m structures, all support such 
conclusions. 
Under native conditions, we and others have shown that a minor population of 
wt β2m is oligomeric, mainly dimeric {Rennella, 2013 #213;Santambrogio, 2010 
#125}. The observation that the disulphide bridge stabilizing DimC33 forms 
spontaneously in solution (in the absence of an added oxidizing agent) is indicative of 
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the spontaneous juxtaposition of two facing C33 residues; it thus strongly suggests 
that the DD interface is the prevalent association interface underlying β2m 
dimerisation under such conditions.  
The aggregation data show that DimC33 is much more amyloidogenic than wt 
β2m, even though its thermodynamic stability and its 3D structure are virtually 
identical to those of the wt protein. Using a standard β2m aggregation protocol in 
20% TFE, we have shown that DimC33 aggregates abundantly, but, opposite to wt 
β2m, does not require fibril seeds for aggregation to start, an indication that DimC33 
can spontaneously form the oligomers required for onset of fibrillogenesis. 
Analogously to wt β2m amyloid formation {Giorgetti, 2010 #137}, doxycyclin 
proved to be an inhibitor of DimC33 aggregation. Taken together, all the above data 
suggest that DimC33 and wt β2m aggregate following very similar processes and end 
products. However, DimC33 was shown to aggregate also in 10% TFE, a condition 
under which the β2m fold is still native (Fig. 1b). The data available to date indicate 
that the amyloidogenic intermediates display a native-like structure {Chiti, 2001 
#25;Karamanos, 2014 #208;Rennella, 2013 #213}; on these bases, a β2m variant, 
such as DimC33, which aggregates under native-like conditions may prove to be an 
proper system to study wt β2m amyloid formation. To the best of our knowledge 
DimC33 is the first model to study β2m aggregation under native-like conditions in 
vitro.  
Recent reports indicate that the first β2m oligomer formed on the pathway to 
fibril association should be a head-to-head elongated dimer {Karamanos, 2014 
#208;Rennella, 2013 #213;Smith, 2010 #128}. In particular, Rennella et al. also 
provided evidence that the dimer association interface should involve the BC loop 
region {Rennella, 2013 #213}, a finding that is in keeping with our previous data and 
with a recently published report {Colombo, 2012 #207;Karamanos, 2014 #208}. In 
this context, we previously showed that hampering the formation of the DD strand 
interface through proper selection of the engineered disulphide bridge results in non-
aggregating β2m covalent dimers {Colombo, 2012 #207}. Thus, the data here 
reported for DimC33, together with previous results, point to the DD strand interface 
as the firstly established protein-protein association interface during β2m aggregation. 
The increased aggregation propensity of DimC33 compared to wt β2m, would then be 
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the result of the immediate availability of the first on-pathway oligomer, that is 
DimC33. 
Interestingly, the crystal structure DimC33 in complex with ThT provides 
further information on the β2m aggregation path. ThT fluorescence is the most widely 
accepted spectroscopic method to discern cross-β fibrils from amorphous aggregate. 
The ThT molecules are held to intercalate the cross-β structure in the fibrils, resulting 
into a gain of fluorescence. Only two structures of ThT in complex with 
amyloidogenic proteins have been so far reported, and both concern β2m {Wolfe, 
2010 #215}. In one of these structures (pdb code: 3MYZ) the authors suggest that 
ThT molecules are simply trapped between β2m molecules packed in the crystal 
lattice, while the second structure reported (pdb code: 3MZT) presents severe 
technical issues that prevent a thorough discussion of ThT-β2m interactions (See 
Supplementary Materials). In this context, the DimC33_ThT structure here reported 
adds substantially new information on ThT binding mode to an amyloidogenic 
protein. In the DimC33_ThT complex structure, the ThT molecules are nestled 
between the ABDE sheets of two facing β2m molecules, in a highly hydrophobic 
environment. Notably, an extended ABDE interface between facing β2m molecules 
can also be observed in the absence of ThT in DimC33_low (this work), and in the 
hexameric β2m structure reported earlier {Calabrese, 2008 #75}. The reciprocal 
orientation of the two facing ABDE β-sheets displays a high level of variability: in 
different crystal structures the facing ABDE β-sheets display varying orientations and 
residue-residue interactions, but in all cases they face each other and the same three 
aromatic residues (Tyr10, Tyr26 and Tyr63) build the hydrophobic core of the β2m 
association interface. Such variability can be accounted for by the presence of several 
Tyr residues and by the capability of hydrophobic interactions to form under different 
orientations of the contributing residues. The above observations point at the ABDE 
β-sheet as a second key interface involved in β2m oligomer formation, in keeping 
with a previous report supports the role of surface aromatic residues in determining 
β2m amyloid propensity {Platt, 2008 #68}.  The structural adaptability of the ABDE 
surfaces may also explain the formation of several different dimeric/tetrameric 
building blocks recently proposed by the EM reconstruction of mature β2m fibrils 
{White, 2009 #117}.  
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In summary, our study presents an engineered β2m covalent dimer, DimC33, 
displaying the same biophysical properties of wt β2m in solution. Nevertheless, 
unlike wt β2m, DimC33 does not require the addition of seeds to start fibrillogenesis, 
and aggregates under native-like conditions. Given that in vivo wt β2m likely 
aggregates from a native-like folded species, DimC33 could then be considered a 
proper model to study β2m oligomerization and fibrillogenesis in vitro, and to test 
new aggregation inhibitors. Finally, the properties and the structures of DimC33 
recapitulate previous evidences and indicate how oligomerisation may proceed during 
aggregation. The first dimeric oligomer would be built across the DD strand interface; 
at a later stage, the aromatic residues located on the ABDE sheet will contribute to the 
formation of a hydrophobic core for further association, leading to trimers and 
tetramers through an structurally adjustable ABDE interface.  
Materials and methods 
Mutagenesis, expression and purification 
The synthetic gene of the Ser33 to Cys β2m variant was purchased from 
Eurofins genomics. The gene of interest was inserted into pET21B expression vector 
and transformed into BL21 (DE3) Escherichia coli strain. The S33C variant β2m was 
expressed and purified as previously reported {Esposito, 2000 #38}. At the end, an 
additional step of purification was introduced to separate the spontaneously formed 
dimeric species of S33C β2m variant by size-exclusion chromatography column 
(Superdex75 16/60 GE healthcare) and eluted with 20mM Sodium Phosphate buffer 
pH 7.4.  
Circular dichroism 
Circular dichroism (CD) studies were carried out on a Jasco J810 
spectropolarimeter equipped with a Peltier system for temperature control and 
analyzed by means of Jasco software. All measurements were recorded at 0.1 mg/mL 
protein concentration in 100 mM sodium chloride, 50 mM sodium phosphate buffer 
pH 7.4 by using a 0.1 cm path length cuvette. Spectra were recorded in plain buffer or 
in buffer added with 10% or 20% TFE at 37 °C. Temperature ramp measurements 
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were recorded at 202 nm from 20 to 95 °C (temperature slope 50 °C/h). Tm values 
were calculated from the first derivative of the recorded traces. 
Aggregation kinetics   
DimC33 aggregation experiments were performed as unseeded reaction by 
incubating samples of 100µL at 37°C for two weeks, without agitation.  
The following aggregation conditions were tested: DimC33_20%TFE (1 mg mL-1 
DimC33 in 20% TFE, 100mM Sodium chloride, 50mM Sodium phosphate buffer pH 
7.4) according to a standard protocol {Yamamoto, 2004 #41}; DimC33_10%TFE (5 
mg mL-1 DimC33 in 10% TFE, 100mM Sodium chloride, 50mM Sodium phosphate 
buffer pH 7.4); DimC33/wtβ2m (a mixture of DimC33 and wt β2m in 1:3 ratio with a 
final protein concentration of 1 mg mL-1 in 20% (v/v) TFE, 100mM Sodium chloride, 
50mM Sodium phosphate buffer pH 7.4). In each experiment aggregation tests on wt 
β2m were also performed as a control. Aggregation kinetics measurements were 
monitored by VARIAN Cary Eclipse spectrofluorimeter by measuring ThT 
fluorescence signal with excitation and emission wavelength of 445 and 480 nm, 
respectively {LeVine, 1993 #40}. 
The inhibitory effect of Doxycycline hyclate on DimC33 aggregation was studied in 
the same aggregation condition as of DimC33_20%TFE, by monitoring ThT 
fluorescence binding signal after one week of incubation at 37°C without agitation. 
Two Doxycycline concentrations were screened: DimC33_Doxy100 containing 
100µM Doxycycline; and DimC33_Doxy400 containing 400µM Doxycycline. A 
DimC33_20%TFE aggregation was used as control model. 
The measurements are the average of three independent experiments. Doxycycline 
hyclate, TFE and ThT were purchased from SIGMA-Aldrich.  
Crystallization and structure determination 
DimC33 was crystallized in three different conditions by mixing equal 
amounts of 8 mg mL-1 protein and reservoir solutions containing: (25% v/v PEG 4K, 
0,2M Imidazole-Malate pH7,0) for DimC33_low, (28% v/v PEG 400, 0,2M Calcium 
chloride dihydrate, and 0,1M Hepes sodium pH7,5) for DimC33_high, and (25% v/v 
PEG 4K, 0,1M Sodium chloride, 5mM ThT, and 0,1M Hepes sodium pH8.0-8.2) for 
DimC33_ThT crystals, respectively. All DimC33 crystals were grown at 20°C 
incubators, using sitting drop vapor diffusion crystallization method.  
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DimC33_low and DimC33_ThT crystals were cryo-protected in 20-33% 
glycerol solution containing the corresponding crystallization condition, and cryo-
cooled in liquid nitrogen. DimC33_low and DimC33_high X-ray diffraction data 
were collected at ID23-1 beam-line (ESRF Grenoble), and DimC33_ThT X-ray 
diffraction data were collected at P13 beamline (PETRA Hamburg). DimC33_low X-
ray data were processed using MOSFLM {Leslie A.G.W., 2007 #30} and SCALA 
from CCP4 software suite {Collaborative Computational Project, 1994 #31} and XDS 
{Kabsch W., 2010 #32} for DimC33_high and DimC33_ThT. The 3D structures of 
DimC33 were determined by molecular replacement using Balbes software suite 
{Long F., 2008 #33}. All structures were refined using Phenix.refine {Afonine P.V., 
2010 #37} and REFMAC5 {Murdushov G.N., 1997 #35}. An amplitude based twin 
refinement protocol was applied during DimC33_ThT refinement process in 
REFMAC5. Model building and structural analysis for all DimC33 structures were 
carried out with COOT {Emsley P., 2010 #34} and figures were prepared with Pymol 
{The PyMOL Molecular Graphics System,  #36}. Structure factors and coordinates 
are deposited in the Protein Data Bank under accession codes: 4R9H for 
DimC33_low, 4RAH for DimC33_high and 4RA3 for DimC33_ThT.  
 
Table 1.  Data collection and refinement statistics for DimC33. 
Values in parenthesis are for the highest resolution shell. 
      Structure (PDB entry) 
DimC33-Low (4R9H) DimC33-High (4RAH) DimC33-ThT (4RA3) 
    Data collection   
Beam line  ID21-3 (ESRF)  ID21-3 (ESRF)  PETRA III, P13 (MX1) 
Space Group  P4122   C2221   P3221 
Unit cell constants (Å)  a=68.84 b=68.84 c=200.04 a=32.35 b=47.70 c=119.65 a=80.04 b=80.04 c=177.70 
Resolution (Å)  65.09 - 1.90 (2.00 - 1.90) 29.91 - 1.40 (1.42 - 1.40) 59.23 - 2.80 (2.95 -2.80) 
Rmerge a(%)  10.9 (94.0)   6.5 (49.5)   5.9 (113.9)   
I/sig(I)  12.4 (2.2)   10.9 (1.9)   21.4 (2.0) 
Completeness (%) 99.9 (99.6)   98.7 (86.6)   100.0 (100.0) 
Redundancy  8.9 (8.3)   4.5 (3.4)   9.6 (10.0) 
Unique reflections 38985 (5533)  18491 (787)  16940 (2432) 
    Refinement 
Rwork b(%)  21.17   16.62   15.08 
Rfree b(%)  24.73   20.94   18.12   
Number of atoms  3480   1021   3407 
Average B, all atoms (Å2) 42.0   17.0   111.0 
Ramachandran plot 
Most favored region 375 (98.68%)   86 (100%)   367 (94.83%) 
Allowed region  4     (1.05%)  0   (0%)   20   (5.17%) 
Outliers  1     (0.26%)  0   (0%)   0   (0%) 
a R merge = ∑hkl  Ihkl - < Ihkl > |/∑hkl  Ihkl  where I is the observed intensity and < I > is the average intensity. 
b R work = ∑hklFo-Fc |/ ∑hklFo for all data except 5% which were used for Rfree calculation. 
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Table 2. The SSM superimposed RMS deviations for DimC33 structures with reference 
models DimC20, DimC50, hexameric H13F β2m and wt β2m. 
DimC20  DimC50 H13F β2m    wt β2m 
(3TLR)  (3TM6)  (3CIQ)  (1JF1) 
DimC33-High(Mono) 0,62/99 Cα  0,59/98 Cα 1,05/97 Cα 0,97/98 Cα 
DimC33-High  2,41/182Cα  2,10/192Cα 1,11/192Cα   - 
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Legends: 
Figure 1. Crystal structure of DimC33 and DD strand interface. (a) Ribbon model 
of a monomeric of DimC33 (blue) superposed on the structure of wt β2m (green). β-
strands are labeled according to standard nomenclature, Cys33 is shown in sticks. (b) 
A zoomed model into DD interface of four superposed crystal structures of 
DimC33_ThT (green), hexameric structure of H13F β2m (magenta), DimC50 (cyan) 
and DimC20 (yellow), showing the main residues involved in the DD interface as 
sticks model. (c) Superposition of four dimers built through the DD strand interface: 
DimC33_ThT (pdb code: 4RA3) in green, hexameric structure of H13F β2m in 
magenta (pdb code: 3CIQ), DimC50 structure in cyan (pdb code: 3TM6), and 
DimC20 structure in yellow (pdb code: 3TLR). (d) Stereo view of the DD strand 
interface formed by the facing molecules as observed in the structure of 
DimC33_high. The main residues involved in the interface are shown in sticks. 
 
Figure 2. Thermal stability and Far-UV spectra analysis by circular dichroism. 
(1a) Temperature ramps for DimC33 in red and wt β2m in black monitored at 202 
nm, temperature slope 50 °C/h. Signals were reported as fractional variation of the 
total change. The melting temperature (Tm) values for DimC33 and wt β2m are 
shown in the graph. (1b) Far-UV spectra for DimC33 and wt β2m in a buffer 
containing 100 mM sodium chloride, 50 mM sodium phosphate buffer pH 7.4, 
recorded at three conditions: No TFE (black curves); in presence of 10% (v/v) TFE 
(red curves); and of 20% (v/v) TFE (blue curves). 
 
Figure 3. DimC33: fibrillogenesis at pH7.4. (a) Kinetics of DimC33 fibril formation 
in100mM NaCl, 50 mM Na phosphate buffer (pH 7.4) at 37°C incubation for two 
weeks, monitored by measuring ThT fluorescence signal at time (hours) 0, 4, 48, 96, 
144, 216, 312. Four samples were screened: DimC33_20%TFE (5 mg mL-1 protein in 
20% TFE); DimC33_10%TFE (1 mg mL-1 protein in 10% TFE); DimC33/wtβ2m 
mixture in 1:3 ratio (1 mg mL-1 protein mixture in 20% TFE); and wtβ2m_20%TFE 
as a control model (1 mg mL-1 protein in 20% TFE). Values represent the average of 
three independent experiments and error bars represent SD. (b) DimC33 aggregation 
inhibition analysis monitored by ThT fluorescence signal after one week of incubation 
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at 37°C, using the same aggregation condition as DimC33_20%TFE in three 
conditions; No Doxycycline (control model), in the presence of 100 µM and 400µM 
Doxycycline. Values represent the average of three independent experiments and 
error bars represent SD. 
 
Figure 4. Crystal structures of DimC33_ThT and DimC33_low. (a) Cartoon 
representation of DimC33 assembly in crystal structure of DimC33_ThT. The three 
DimC33 units colored in cyan, green and magenta. Two ThT binding sites are visible: 
on the right the 4ThT site (four ThT molecules are colored in blue); while on the left 
side, the 1ThT site where the ThT molecule is colored in red. (b-c) A zoomed 
representation into 1ThT site (b) and into 4ThT site (c) showing ThT molecules 
sandwiched between the ABDE sheets of the two adjacent DimC33. (d) Ribbon 
represenation of ABDE interface observed in the DimC33_low (pdb code : 4R9H). (e) 
Ribbon represenation of ABDE interface as found in the hexameric structure of H13F 
β2m (pdb code: 3CIQ).  
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Supplementary 
 
Analysis of 3MZT Structure 
The structure with the PDB code 3MZT was reported as a complex of hexameric 
H13F β2m mutant together with Thioflavin (ThT). The structure was determined to 
2.70Å resolution. Three ThT molecules have been modeled sandwiched at the three of 
the intermolecular interfaces present in the hexameric assembly. All three ThT 
molecules have been modeled in two alternative but almost superposable 
conformations (0.5 occupancy each). Temperature factors for ThT atoms range 
between 80 and 120 Å2 for each of the two conformations. 
Furthermore, once the structure was refined in absence of the ThT molecules the 
residual electron density for ThT is reduced to a little blob of the size of a water 
molecule. 
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  ABSTRACT  
Beta-2 microglobulin (β2m) is the protein responsible for a pathologic condition 
known as dialysis related amyloidosis. In recent years an important role has been assigned to 
the peptide loop linking strands D and E (DE loop) in determining β2m stability and amyloid 
propensity. Several mutants of the DE loop have been studied, showing a good correlation 
between DE loop geometrical strain, protein stability and aggregation propensity. However, it 
remains unclear whether the aggregates formed by wild type (wt) β2m and by the DE loop 
variants are of the same kind, or whether the mutations open new aggregation pathways. In 
order to address this question, fibrillar samples of wt and mutated β2m variants have been 
analysed by means of atomic force microscopy and infrared spectroscopy. The data here 
reported indicate that the DE loop mutants form aggregates with morphology, structural 
organisation and dynamics very similar to the wt protein. Therefore, the main effect of β2m 
DE loop mutations is proposed to stem from the different stabilities of the native fold. 
Considerations on the structural role of the DE loop in the free monomeric β2m and as part of 
the Major Histocompatibility Complex are also presented. 
	  INTRODUCTION 
Amyloidosis is characterized by the conversion of a protein from its native state into 
insoluble highly organized fibrillar aggregates, being at the roots of several protein 
misfolding diseases in man, such as Alzheimer, Parkinson and Huntington diseases [1]. β2-
microglobulin (β2m) is the light chain of class I major histocompatibility complex (MHC-I) 
[2]. It is a 99-residue protein displaying a classic immunoglobulin fold, based on two facing 
β-sheets that are linked by a disulphide bond. Under physiological conditions, β2m turnover 
takes place in kidneys, where it is degraded. In case of renal failure, the degradation of β2m 
does not occur, and the protein accumulates in the blood increasing its concentration up to 50-
fold in hemodialysed patients [3]. When such high β2m blood level is retained over the years, 
the protein self-associates into amyloid fibrils [4], which accumulate around the skeletal 
joints, bones and muscles. Such condition, known as dialysis related amyloidosis, is 
characterized by typical symptoms such as movement impairment, bone fragility, and carpal 
syndrome [4].  
Somehow contradictory is the observation that in vitro β2m is a very stable protein, 
reaching mM concentrations without precipitating or aggregating, and yet in vivo at much 
lower concentration β2m turns into amyloid deposits [5]. Although several factors, such as 
type I collagen and glycosaminoglycans (GAGs) [6-8] have been reported to facilitate β2m 
aggregation, very little light has been shed on the β2m regions that trigger or mediate the 
fibril formation. 
Many studies have shown the relevance of different β2m stretches in determining the 
protein aggregation propensity. Among others, the cis to trans isomerisation of Pro32, in the 
BC-loop, has been shown to be one of the fundamental steps of the conversion from the 
native fold to the amyloidogenic intermediate [9]; in keeping with this observation, no cis-Pro 
residues have been observed in the mature β2m fibrils [10]. Moreover, the N-terminal six 
residues are known to stabilise the β2m fold; accordingly, the natural variant ΔN6 (i.e. β2m 
	  devoid of the first six residues) is highly amyloidogenic [11]. Notably, the natural β2m 
mutant (D76N), recently discovered, highlights the role of the EF loop in determining β2m 
stability and aggregation propensity [12].  
Over the years Trp60 and in general the β2m DE-loop (residues 57-60) have been 
shown to be crucial in determining many of the wild type (wt) β2m biochemical and 
biophysical properties (Fig. 1A) [13-15]. Trp60 is a highly conserved residue in vertebrate 
β2m, being primarily involved in the association interface linking β2m to the heavy chain 
within the MHC-I complex [16]. We recently showed that the interactions within the MHC-I 
complex greatly stabilise the β2m fold (Fig. 1B) [17]; however, while the DE-loop is 
designed to play a role in formation of the MHC-I complex, it appears as an element of 
instability for monomeric β2m in solution. Many data collected over the past few years 
support such view. First of all, the DE-loop displays a non-ideal backbone geometry [16,18]. 
In order to test whether the DE-loop geometry might be relevant for β2m biochemical and 
aggregation properties, Trp60 was mutated to Gly, to obtain a less strained DE-loop (W60G 
mutant) [16], and to Val, to verify the effect of the Trp side chain alone (W60V mutant) [18]. 
Asp59 was mutated to Pro (D59P mutant), to evaluate the effects of an even more rigid DE-
loop on the overall β2m molecule [19]. β2m thermodynamic stability, measured by 
temperature and chemical unfolding, correlates well with the DE-loop geometry [15]. 
Aggregation kinetics indicate that the lower is the thermodynamic stability, the faster and 
more abundant is the aggregation [13]. However, other data are indicating some direct role of 
Trp60 in β2m aggregation: first of all electrospray-mass spectrometry under native conditions 
showed that while wt β2m in solution presents a non-negligible population of small 
oligomers, the mutant W60G and W60V showed markedly reduced tendency to native 
aggregation [15]. Under standard conditions the W60V mutant is aggregating less abundantly 
than wt β2m [18]. 
Overall, the above evidence clearly indicates that the DE-loop is a major determinant 
of β2m fold thermodynamic stability and aggregation propensity. However, one main 
	  question about the effect(s) of the DE-loop mutations on β2m amyloid aggregation remains 
open. The mutations in the DE-loop may result in thermodynamic (de)stabilization of the 
native protein, which in turn can alter the kinetic barrier(s) along the aggregation process, 
while the aggregation pathway remains unaltered. An alternative possibility is that such 
mutations may affect β2m aggregation propensity by opening new aggregation pathways and 
leading to different and unrelated kind(s) of β2m aggregates. To address this question, we 
performed a comparative biophysical characterisation of amyloid aggregates formed by wt 
β2m and DE loop mutants. In particular, the morphology and structural organization of early 
aggregates and mature fibrils have been analysed by Atomic Force Microscopy (AFM); then, 
the dynamics and the overall secondary structure content for the fibrils of the four β2m 
variants have been monitored by Fourier transform infrared (FTIR) spectroscopy. Previous 
data showed that the DE loop mutations exert a major effect on the stability of the β2m native 
fold and affect the aggregation kinetics [13, 15] while the experiments here presented indicate 
that the fibrils of the DE loop variants and of wt β2m have comparable architecture and 
dynamics, suggesting that mutations at the DE loop effects are limited to the β2m aggregation 
process, and do not alter the end stage of the aggregation pathway. 
 
METHODS 
Sample preparation 
Wt β2m and the three mutated variants (W60G, D59P, W60V) were expressed and 
purified as previously described [16].  
The aggregated samples were prepared as follows: 100 µM β2m was incubated at 37 
°C under shaking (600 rpm) in 50 mM Na phosphate buffer, 100 mM NaCl, pH 7.4, in the 
presence of 20% (v/v) TFE [20]; 20 µg/ml of β2m fibril seeds were added to the samples. Wt 
β2m and its variants were incubated for 24 h or for one week under the aggregation 
	  conditions. The formation of fibrillar aggregate has been monitored by measuring Thioflavin 
T (ThT) fluorescence according to LeVine [21]. 
 
Atomic force microscopy 
For AFM inspection, samples were diluted 500-fold and a 10 µl aliquot was 
deposited on a freshly cleaved mica substrate, and dried under mild vacuum. Alternatively, to 
recover fibrillar material, samples were centrifuged at 4000 rpm for 10 min using an 
Eppendorf 5417R centrifuge, the pellet was suspended in an equal volume of water, and a 10 
µl aliquot was deposited on mica and dried under mild vacuum. 
AFM images were acquired in tapping mode in air using a Dimension 3100 Scanning 
Probe Microscope equipped with a ‘G’ scanning head (maximum scan size 100 µm) and 
driven by a Nanoscope IIIa controller, and a Multimode Scanning Probe Microscope 
equipped with ‘‘E’’ scanning head (maximum scan size 10 µm), driven by a Nanoscope IV 
controller (Digital Instruments – Bruker). Single beam uncoated silicon cantilevers (type 
OMCL-AC160TS, Olympus) were used. The drive frequency varied between 270 and 330 
kHz, the scan rate was between 0.5 and 0.8 Hz. Aggregate size was measured from the height 
in cross section of topographic AFM images. 
 
Fourier transform infrared spectroscopy 
The infrared absorption spectra were collected in the attenuated total reflection 
(ATR) mode on a single reflection diamond element (Golden Gate, Specac, USA). The fibrils 
of the β2m variants, obtained by centrifugation at 17000 x g for 15 min at 4°C and 
resuspended in the fibrillogenesis buffer for a second centrifugation, were transferred to the 
ATR plate and dried at room temperature in order to obtain a protein hydrated film [22-24]. 
In order to study the hydrogen/deuterium (H/D) exchange of the sample, the FTIR spectra 
were collected on the protein films before and after the addition of 3µL of D2O [22]. FTIR 
measurements were performed using the Varian 670-IR spectrometer (Varian Australia Pty 
	  Ltd, Mulgrave VIC, Australia) under the following conditions: 2 cm-1 resolution, a scan speed 
of 25 kHz, triangular apodization, and a nitrogen-cooled Mercury Cadmium Telluride 
detector. In order to follow the H/D exchange kinetics, the number of scan coadditions was 
adjusted from 15 (immediately after D2O addition) to 2000 (starting from about 6 hours after 
D2O addition). The measured spectra were smoothed by the Savitsky-Golay method before 
the second derivative analysis, both performed by the Resolutions-Pro software (Varian 
Australia Pty Ltd, Mulgrave VIC, Australia). As controls, the same FTIR characterisations 
have been performed on the native wt β2m (at 5 mg/mL concentration in Na phosphate buffer 
50mM, pH 7.4) and on the supernatant of W60G mutant. In this last case, after one week 
incubation under fibrillogenesis conditions, the W60G sample was centrifuged at 17000 x g 
for 15 min at 4°C and the supernatant was concentrated three times by a centrifugal filter 
device (Microcon, Millipore Corporation, Bedford, MA, USA) at 4°C. The protein film, 
obtained from a supernatant volume of 3µL, was subjected to the FTIR characterisations as 
described above for the β2m fibrils.  
 
RESULTS 
Amyloid fibril preparation 
Purified samples of wt β2m and of the three DE loop variants have been placed under 
standard aggregation conditions (see methods). Aggregated samples after 24 hours and after 
one week incubation have been tested for thioflavin fluorescence (Table I) and have been 
analysed by means of AFM and FTIR.  
 
Characterisation of the amyloid aggregates by AFM 
Tapping mode AFM allowed us to inspect the morphologies of the β2m aggregates 
formed by the different variants. Representative images of the samples aggregated for 24 h, 
	  and deposited on the mica substrate after dilution, are reported in Figure 2. Wt β2m mainly 
displayed isolated oligomers with a height of 5-10 nm, or oligomer chains (Fig. 2A), while 
the D59P variant extensively formed planar sheets of fibrils, about 4 nm high (Fig. 2B). The 
height of these fibrils is significantly lower than that measured for mature fibrils, suggesting 
that the thinner fibrils are either intermediate structures or structures resulting from an 
epitaxial growth induced by the mica substrate. In any case, they reflect a strong tendency to 
fast aggregation, which is distinctive for this variant. Large oligomer clusters were observed 
for the W60V variant (Fig. 2C). For the W60G variant, oligomers with a height of 8 - 15 nm, 
and very short protofibrils formed by few oligomeric units, were found (Fig. 2D). Mature 
fibrils were not observed for any of the variants, probably due to the relatively low fraction of 
fibrillar material. Therefore, samples were centrifuged and the pellet was analysed to check 
for the presence of mature fibrils. In all cases except for W60G β2m, mature fibrils were 
abundant in the pellet and were intertwined in clusters (Fig. 2E-G). A different behaviour was 
found for the W60G variant, which exhibited only very short, almost isolated, fibrillar 
structures (Fig. 2H).  
To increase the fraction of fibrillar material and ensure that all the variants yielded 
mature fibrils, aggregated samples incubated for one week were prepared. Topographic 
images of the mature fibrils obtained for the wt and the different mutants after prolonged 
incubation are shown in Fig. 3A-D. Both wt β2m and the variants formed fibril clusters, but 
for the W60G mutant the cluster size was smaller than for the other variants. In many cases 
fibrils exhibit a twist with a periodicity varying between 40 and 60 nm. The fibril height 
distributions are reported in Fig. 3E-H. All the height distributions share a main peak at about 
7 nm, indicating the presence of a common fibrillar structure as a main component. However, 
for W60V β2m the measured height values span a much broader range than in other cases, 
indicating the formation of more complex assemblies, which can still be recognized as 
isolated fibrils. W60G β2m fibrils are shorter than those formed by the other variants. The 
fibril mean lengths were (28±5)⋅10 nm, (70±1)⋅10 nm and (40±6)⋅10 nm for W60G β2m, 
	  W60V β2m and D59P β2m, respectively. For wt β2m, most fibrils were so closely 
intertwined that single fibrils could not be distinguished, preventing an estimate of the fibril 
length. 
Collectively, the results of the AFM analysis suggest that a common mechanism of 
fibril formation takes place for wt β2m and the variants, although the details of the 
aggregation process can be different. The differences observed between the variants may be 
ascribed to their different aggregation propensities.  
 
Structure and dynamics of amyloid fibrils monitored by FTIR 
The structural properties of the wt and DE loop β2m variants were examined by FTIR 
spectroscopy. In particular, we studied the fibril secondary structures and the 
hydrogen/deuterium (H/D) exchange kinetics of their core intermolecular β-sheet structures. 
As control experiments, the FTIR absorption spectra of the native wt β2m were also 
measured before and after D2O addition  (Fig. 4A-C). To disclose the protein secondary 
structures the second derivatives of the absorption spectra were obtained (Fig. 4B) [25,26]. 
The Amide I band (1700-1600 cm-1) of native wt β2m is characterised by the two components 
at ~1637 cm-1 and at ~1691 cm-1 that can be assigned to the intramolecular antiparallel β-sheet 
structures of the protein, in agreement with previous FTIR characterisations [13,27,28]. Other 
minor components (Fig. 4B) around 1678 cm-1 and 1668 cm-1 (assigned to turns) and around 
1614 cm-1 (likely due to β-sheets or amino acid side-chains) were observed [13,27-29]. Upon 
the addition of D2O, a fast reduction of the band at 1535-1537 cm-1 (Amide II band mainly 
due to the amide groups NH bending vibrations) takes place with a simultaneous increase of 
the band at 1443-1447 cm-1 (called Amide II’), evidence of the H/D exchange (Fig. 4A), 
where the amide protons in accessible protein regions are replaced by deuterium [22]. The 
exchange of the different protein secondary structures can be monitored by the downshift of 
their peak positions in the second derivative spectra, as reported in Figure 4C. In particular, 
the main intramolecular β-sheet component of native wt protein downshifted from ~1637 cm-1 
	  to ~1633 cm-1 (Fig. 4B and 4C), whereas the high-wavenumber β-sheet component 
downshifted from ~1691 cm-1 to ~1682 cm-1. The final peak positions of the native β-sheet 
components obtained in the D2O-hydrated film are in agreement with those found for the 
deuterated β2m in previous FTIR studies performed in transmission mode [13,27,30].  
The FTIR absorption spectra of fibrillar wt β2m and their second derivatives are 
reported in Figures 4D and 4E, respectively. The main Amide I component occurs around 
1621 cm-1 that, with the 1693 cm-1 weaker component, can be unambiguously assigned to the 
intermolecular β-sheet structures of the undeuterated fibrils. The assignment of the additional 
components in the 1675-1634 cm-1 spectral region is not unequivocal. Indeed, as discussed in 
the literature [25,27,30-32], they can be assigned to turns (typically in the 1686-1660 cm-1 
range), to loops (typically in the 1650-1640 cm-1 range), to native-like structures (around 1634 
cm-1) or to a peculiar arrangement of the β-strands in the protein supramolecular assemblies 
[30]. We should note that the relative intensities of these components displayed a slight 
heterogeneity in independent fibril preparations; therefore, in Figure 4E two representative 
second derivative spectra of wt (undeuterated) fibril films are reported. 
To study the dynamics of the fibril core β-sheet structure, H/D exchange experiments 
were performed, as reported in Fig. 4D-F. In particular, during incubation in D2O, the main 
intermolecular β-sheet peak downshifted from ~1621 cm-1 in the undeuterated fibrils to ~1618 
cm-1 after 23 hours of incubation in D2O (Fig. 4E and 4F). The same characterisations have 
been performed on the fibrils of the DE-loop mutants  (Fig. 5).  
The undeuterated fibrils of D59P and of W60V variants share with aggregates of wt 
β2m the same two main Amide I components around 1693 cm-1 and 1621cm-1 that can be 
assigned to the intermolecular β-sheet structures (Fig. 5B and 5D). This result is in agreement 
with previous FTIR characterizations [13] on the same b2m variants studied here. Indeed, in 
these earlier experiments, the aggregation of unseeded wt and DE loop mutants took place 
inside the infrared cell, leading to final aggregates characterized by the same intermolecular 
β-sheet Amide I’ components. 
	  Concerning the H/D exchange experiments presented in this work, as observed for wt 
fibrils, the main intermolecular β-sheet peak of D59P and of W60V fibrils was found to 
downshift from ~1621 cm-1 to around 1618 cm-1 after 23 hours of incubation in D2O (Fig. 5A-
D). The time dependence of this peak position is reported in Figure 5E for the wt, D59P, and 
W60V variants. A similar H/D exchange kinetics was observed for these three variants as can 
be seen from the partially overlapped standard deviations of independent fibril preparations 
(Figure 5E). Indeed, the fibril second derivative spectra of the variants displayed similar 
Amide I components, with the main intermolecular β-sheet band peaked at the same 
wavenumber and characterized by a comparable H/D exchange (Fig. 4-5). These results 
suggest that the fibrils of the three variants are characterized by comparable intermolecular β-
sheet structures and dynamics. However, the relative intensity of the other weaker Amide I 
components (at ~1647-1644 cm-1 and ~1634 cm-1) was found to vary in the final fibrils of the 
variants, indicating that minor structural rearrangements occurred in the presence of the 
mutations.  
In agreements with the low aggregation propensity of the W60G mutant [13,16], a 
low amount of fibrils was obtained by centrifugation of this sample after 1 week incubation 
under fibrillogenic conditions. The absorption spectrum of the W60G fibrils displayed the 
same Amide I maximum as observed for the other variants (Fig. 5F). Unfortunately, the low 
amount of the collected W60G fibrils did not allow to obtain high quality ATR/FTIR spectra 
suitable for second derivative analysis and H/D exchange experiments and a significant 
amount of the W60G protein was instead found in the supernatant. In particular, the spectrum 
of the supernatant (Fig. 5F and 5G) displayed two main components at ~1691 cm-1 and at 
~1636 cm-1, assigned to native-like intramolecular β-sheet structures, which after 23 hours 
incubation in D2O downshifted, respectively, to ~1688 cm-1 and ~1634 cm-1. 
All this considering, the FTIR results indicate that the wt β2m and the three DE loop 
variants investigated here (D59P, W60V, W60G) formed, under the same aggregation 
conditions, amyloid fibrils characterized by a common intermolecular β-sheet structure, with 
comparable H/D exchanges, and by limited structural differences among the different 
	  mutants.  The previously reported low aggregation propensity of the W60G mutant was also 
confirmed here [13,16]. 
 
DISCUSSION 
Amyloid aggregation is a life threatening process, which is at the basis of many 
severe pathologic conditions. Protein aggregation is a complex process, and the heterogeneity 
of such process adds serious challenges to its structural and biophysical characterisation. The 
lack of detailed structural data on amyloid formation undermines our understanding of the 
pathologic process and hampers the design of pharmacological therapies. Over the last 10-20 
years one of the most successful strategies to gather biochemical and biophysical evidence on 
protein aggregation has been to mutate the polypeptide sequence, testing the aggregation 
properties of the mutated variants, thus inferring the role played by selected residues during 
amyloid aggregation. However, mutations may introduce several independent effects; 
mutations can subtly affect the structure of the protein, its dynamics, its thermodynamic 
stability, the energetic barriers between different states etc. Therefore, not only is it crucial to 
observe that a modified aggregation propensity stems from a specific mutation, but it is also 
necessary to understand which effect(s) the mutation exerts on aggregation end point. In 
particular, many cases are known where mutations lead to off-pathway states or trigger a 
different kind of aggregation. The elegant crystal structure of hexameric β2m reveals many 
interesting intermolecular interactions, however such hexameric form does not aggregate 
under standard conditions [33], leaving open the question on which are the interactions that 
set the hexamer off-pathway. Specific mutations may structurally protect the protein from the 
aggregation pathway undertaken by the wt protein, but in parallel open new paths to amyloid 
formation, as recently exemplified by protective mutations on Acylphosphatase from 
Sulfolobus solfataricus [34,35].  
	  To date, using different techniques, we have shown that many marked effects 
stemmed from mutations in the DE loop: thermodynamic stability and aggregation propensity 
vary according to the DE loop geometry [15,18]. However, in order to draw conclusions on 
the role of the DE loop on β2m amyloid aggregation it is crucial to establish whether the final 
step of aggregation (i.e. the amyloid fibrils) is maintained. Should the starting and the end 
points of the aggregation process be conserved in wt β2m and in the mutants, we could 
propose a conservation of the aggregation process for the four explored variants. In such a 
scenario the effects previously observed upon mutations in the DE loop could be discussed in 
the context of the wt protein aggregation process. Conversely, formation of aggregates by the 
DE loop mutants not sharing structural features with those displayed by the wt protein would 
imply the onset of distinct aggregation pathway(s), ultimately preventing us from assigning 
any role to the DE loop in the aggregation of wt β2m. Based on such considerations, we 
deemed relevant to investigate the nature of the amyloid aggregates produced by the DE loop 
mutants, compared to those formed by wt β2m, to clarify the role played by the loop on β2m 
amyloid propensity.  
First, quantitative information about aggregate size and shape has been obtained by 
AFM. The images acquired from samples incubated for 24 hours confirm, as previously 
reported [13], that wt β2m and the three DE loop variants display different aggregation 
kinetics. In particular, D59P β2m exhibited a fast aggregation, giving rise to sheets of thin 
fibrils, which were not observed either in wt β2m or in the other variants. W60G β2m showed 
the slowest aggregation, as after 24 hours fibrils were rare and short even in the pellet, 
differently from the other samples. In the pellets of samples incubated for a week, mature 
fibrils were found for wt β2m and the three variants. The analysis of fibrils cross-sections 
indicates that in all cases the fibril populations share a peak at about 7 nm in the height 
distributions. The fibril heights observed for the samples analysed in the present study are 
consistent with those reported by Ohhashi et al. for wt β2m fibrils formed at neutral pH by 
ultrasonication in the presence of SDS [36]. Although these aggregation conditions are not the 
	  same as in our study, they can be considered as somewhat equivalent; in fact, it has been 
observed that both TFE and SDS act as hydrophobic co-solvents favouring fibrillation [37].  
The AFM analysis indicates that despite differences in the aggregation kinetics, the 
wt β2m and three mutants give rise to fibrils with comparable heights that suggest a common 
fibrillar architecture. Moreover, the secondary structure content detected by ATR/FTIR in 
mature aggregates, shows that all four kind of fibrils are characterised by the same Amide I 
components due to the intermolecular β-sheet structures of the final protein assemblies. 
Finally, H/D exchange was employed to evaluate structural dynamics, compactness, and 
stability, providing information on fibril molecular packing. In keeping with the biophysical 
characterizations reported above, H/D exchange kinetics observed for wt β2m and the DE 
loop mutants aggregates are well comparable, further suggesting that the overall fibril 
assembly is shared among the four protein variants.  
 
CONCLUSIONS 
In summary, the data presented here suggest that the mutations in the DE loop do not 
alter significantly the overall structural properties of the β2m amyloid aggregates. Given that 
β2m native fold and the mature fibrillar aggregates appear unaltered ([18] and this work), we 
propose that the aggregation process is conserved for the β2m mutants examined here, and 
that the DE loop is a crucial region determining the wt β2m aggregation propensity, affecting 
the aggregation kinetics. In particular, it has been found that the DE loop has a strong 
thermodynamic influence on the β2m native state. This loop is a source of instability that 
likely determines the energies associated with the different folded states and the energetic 
barriers between them, resulting in the aggregation propensity observed for monomeric wt 
β2m. By simple modifications of residues and of the geometry in this loop it is possible to 
tune the stability of the β2m fold and to practically abolish (or to increase) β2m amyloid 
formation. Such observations can be reconciled with the evolution of β2m as structural part of 
	  the MHC-I complex. Notably the DE loop of human β2m has the main role of properly 
orienting Phe56 (just upstream the loop) and Trp60 for the interaction with the heavy chain in 
the MHC-I (Fig. 1B). The presence and the positioning of the bulky Trp60 side chain is ideal 
for the interaction with an amphipathic cleft of the neighbouring heavy chain; therefore in 
general the loop strained geometry and the overall β2m fold are efficiently stabilised by the 
tight interactions between β2m and the heavy chain in the MHC-I complex [17]. However, 
once wt β2m is released in the blood as a monomer, even if it is globally very stable, it 
presents in the DE loop all the ingredients for misfolding: a conformational strain which 
makes the D strand and DE loop region flexible and unstable [16], and a patch of solvent-
exposed aromatic side chains in the D and E strands and in the DE loop, which will drive an 
overall entropy gain upon protein aggregation (see also [38]).  
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LEGENDS: 
Figure 1: DE loop in monomeric β2m and in interaction within the MHC-I 
(A) Ribbon representation of monomeric β2m (PDB code 2YXF). The DE loop 
residues are shown in yellow sticks. (B) Stereo view of the DE loop and Phe56 (yellow 
sticks) when interacting with the heavy chain in the MHC-I (electrostatic surface and green 
sticks). Trp60 is establishing a H-bond with Asp122 from the heavy chain (PDB code 4L29). 
Figure 2: AFM characterisation of wt β2m and DE loop mutants aggregates 
incubated for 24 h 
Tapping mode AFM images (top, height data; bottom, amplitude data) of wt β2m and 
DE loop mutants aggregated for 24h. Scan size 1.4 µm; Z range A) 30 nm; B) 35 nm; C) 100 
nm; D) 60 nm. E-H) fibrils found in the pellets of samples A-D). Scan size 860 nm.  
Figure 3: AFM characterisation of wt β2m and DE loop mutants aggregates 
incubated for one week 
Tapping mode AFM images (height data) of mature fibrils of wt β2m and DE loop 
mutants obtained after one week incubation. Scan size 1.2 µm; Z range: A, D) 55 nm; B) 70 
nm; C) 65 nm. E-H) histograms of fibril height measured from fibril cross-sections in the 
topographic AFM images.  
Figure 4: ATR/FTIR characterisation of wt β2m in the native and the fibrillar 
state.  
A) The absorption spectra of the native β2m in form of a protein film were collected 
before and after incubation in D2O for different times. Spectra are reported in the regions of 
Amide I (AI), Amide II (AII), and Amide II’ (AII’). Arrows point at increasing incubation 
time in D2O. Absorption spectra are normalized at the Amide I maximum. B) Second 
derivatives of the absorption spectra of (A) in the Amide I region. The spectra collected after 
	  D2O addition were normalized at the tyrosine band [31]. The marked peak positions of the 
two components due to the native antiparallel β-sheet structures refer to the spectrum of the 
undeuterated sample. C) Time course of the peak position of the main native β-sheet 
component reported after D2O addition to the protein film. Error bars represent the standard 
deviation of three independent samples. The peak positions were taken from the second 
derivative spectra. D) Absorption spectra of the wt β2m fibrils collected before and after 
incubation in D2O, reported as in (A). E) Second derivatives of the absorption spectra of (D) 
in the Amide I region. Spectra of two undeuterated fibrils obtained from independent 
preparations are compared to show fibril heterogeneity. The spectra collected after D2O 
addition were normalized at the tyrosine band [31]. The peak positions of the main 
components are indicated. F) Time course of the peak position of the main intermolecular β-
sheet component is reported after D2O addition. Error bars represent the standard deviation of 
three independent fibril preparations. The peak positions were taken from the second 
derivative spectra. 
Figure 5: ATR/FTIR characterisation of DE loop mutants in the fibrillar state. 
A) The absorption spectra of the D59P fibrils were collected before and after 
incubation in D2O for different times. Spectra are reported in the regions of Amide I, Amide 
II, and Amide II’ bands. Arrows point to the spectral changes at increased incubation time in 
D2O. Absorption spectra are normalized at the Amide I maximum. B) Second derivatives of 
the absorption spectra of (A) in the Amide I region. The spectra collected after D2O additions 
were normalized at the tyrosine band [31]. The peak positions of the main components are 
indicated. C) The absorption spectra of the W60V fibrils were collected before and after 
incubation in D2O for different times and reported as in (A). D) Second derivatives of the 
absorption spectra of (C) in the Amide I region. E) Time course of the peak positions of the 
main intermolecular β-sheet component of wt, D59P, and W60V amyloid fibrils are reported 
after D2O addition to the protein films. Error bars represent the standard deviation of at least 
three independent fibril preparations. The peak positions were taken from the second 
derivative spectra. F) The absorption spectra of W60G, wt, D59P, and W60V fibrils and that 
	  of W60G supernatant are reported in the Amide I region. The intermolecular β-sheet structure 
absorption band is marked. G) Second derivative spectra of the W60G supernatant collected 
before and after 23 hours from D2O addition. The peak positions of the main components are 
indicated.  
 
Striking image 
 
Tapping mode AFM image (height data) of mature fibrils of the W60G variant. Scan size 1.2 
µm; Z range 55 nm. 
 
Table I. Amyloid fibril formation of wt β2m, D59P, W60G and W60V β2m variants 
monitored by ThT fluorescence (given in arbitrary units). 
 wt β2m D59P β2m  W60G β2m  W60V β2m 
24 hour incubation 40 (± 2) 46 (± 4) 18 (± 1) 29 (± 1) 
1 week incubation 79 (± 21) 62 (± 15) 12 (± 2) 69 (± 22) 
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